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ABSTRACT
Several neurochemical correlates of synaptically- 
active amino acids, including high affinity, sodium-dependent 
uptake into brain slices, calcium-dependent potassium- 
stimulated release from brain slices and convulsions induced 
by antagonists of postsynaptic action, were examined with 
respect to glycine and GABA in the CNS of young rats.
Results suggest that these compounds are functioning as 
inhibitory transmitters in rats of 1-day postnatal age, the 
earliest developmental stage studied.
Two enzymes, serine hydroxymethyltransferase 
and glycine:2-oxoglutarate aminotransferase were measured 
in various regions of rat and cat CNS, and compared with 
glycine levels in these areas. While no correlation was 
found between the activity of either enzyme and glycine 
levels in five regions of the rat CNS, there was some 
correlation between the activity of serine hydroxymethyl- 
transferase and glycine levels within cat spinal cord. 
Measurement of the levels of serine hydroxymethyltransferase 
in rats at different stages of development indicates that 
this enzyme, which decreases in activity from birth to 
maturity, correlates with cell growth rate.
Glycine is the only amino acid found in 
significantly higher concentration in the spinal cord than 
any other region of 10-day-old rats. The increasing 
rostro-caudal gradient of glycine levels, so prominent in 
adult animals, is apparent in 10-day-old animals.
D-aspartate is accumulated by rat brain slices. 
Results indicate that uptake is by that system specific 
for the dicarboxylic amino acids. The similarity of uptake
Vof D- and L-aspartate and the observation that D-aspartate 
can be released from brain slices by a depolarizing 
stimulus suggest that D-aspartate may be a useful compound 
in studying the neurotransmitter role of L-aspartate, 
particularly as it is only slowly metabolized in the CNS.
D-aspartate oxidase activity has been demonstrated 
in the mammalian brain. When assayed in vitro, with 
molecular oxygen as electron-acceptor, this enzyme is 
far more active on D-aspartate than D-glutamate and has no 
activity on those D-amino acids which are oxidised by D-amino 
acid oxidase. Levels of D-aspartate oxidase in the CNS 
are much lower than in the kidney.
No D-aspartate could be detected in extracts of 
cat and rat CNS. If present, it would have to be so at a 
level of less than 1% of the L-isomer.
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I GENERAL INTRODUCTION
1A great volume of research has centred on the 
involvement of acetylcholine and the monoamines, noradrenaline, 
dopamine and serotonin, in peripheral transmission and in 
the central regulation and control of behaviour, emotion 
and basic drives such as hunger, thirst, aggression and 
sleep. Major advances have been made in biochemical, 
histochemical and pharmacological techniques for studying 
these substances. These studies have led to the widespread 
assumption that they are quantitatively major transmitters 
in the mammalian CNS. However, the biogenic amines and 
acetylcholine together probably account for transmission 
at only a small portion of central synapses (SNYDER, YOUNG, 
BENNETT & MULDER, 1973). Thus, in the corpus striatum, the 
brain region richest in dopamine, only about 15% of nerve 
terminals appear to contain catecholamines, while in the 
hypothalamus, which contains the highest levels of 
noradrenaline, only about 3-5% appear to contain catecholamines 
(HÖKFELT, 1970). About 5% of all synaptosomes in cerebral 
cortex homogenates appear to be noradrenergic (IVERSEN &
SCHON, 1973). Since the brain contains less serotonin than 
catecholamines, this compound may account for yet a lower 
percentage of synapses. Acetylcholine has been shown to 
be the transmitter released at terminals of motorneuron 
axon collaterals onto Renshaw cells (ECCLES, FATT & KOKETSU, 
1954), but no specific cerebral pathway has been conclusively 
shown to act by release of acetylcholine; it is probably 
only associated with a small percentage (about 10%) of 
nerve terminals (MCLENNAN, 1970) .
On recent evidence it appears that the amino acids, 
particularly GABA, glycine, glutamate and aspartate, account 
for transmission at a substantial proportion of central 
synapses. With more experimental, evidence, taurine and
2proline may eventually be added to this list. Based on
the assumption that the neuronal uptake of amino acid
transmitter candidates by high affinity uptake systems is
specific for those neurons using them as transmitters,
autoradiographic studies of CNS tissue after either in vivo
or in vitro radioactive amino acid labelling have been
performed to determine which neuron terminals accumulate
3them. The proportion of terminals labelled with [ H3 GABA 
in cerebral cortex slices was 27%. In slices prepared from 
other regions this value varied from 14% in the molecular 
layer of the cerebellum to 51% in the substantia nigra 
(IVERSEN & SCHON, 1973). Very similar results were obtained 
with the proportion of synaptosomes labelled after incubation 
of homogenates with GABA. In spinal cord homogenates 25%3of pinched-off nerve terminals were labelled. [ H]glycine
labelled 28% of synaptosomes in spinal cord homogenates,
3 3while incubation with both [ h JgABA and [ H]glycine resulted
in 51% of terminals being labelled (IVERSEN & BLOOM, 1972).
3To date, no electron microscope autoradiography of [ H]3aspartate or [ H]glutamate has been reported (IVERSEN & SCHON, 
1973).
Amino acids have only recently been proposed as 
possible CNS neurotransmitters. The evidence .or certain 
amino acids acting as synaptic transmitters pertains to 
the following criteria for transmitter identification (CURTIS 
& JOHNSTON, 1970):
1. The substance, and possibly the enzymes for its 
synthesis, should be present in or accumulated 
by the appropriate nerve endings.
2. The substance should be released following impulses 
in the appropriate nerve fibres.
The postsynaptic action of the substance should 
be identical with that of the natural transmitter.
3.
34. Compounds which block synaptic transmission by
a specific postsynaptic effect must also antagonize 
the action of the suspected transmitter.
5. The processes which inactivate or remove the 
released transmitter should also terminate the 
action of the artificially administered substance.
These criteria for transmitter identification have generally 
proved acceptable in the identification of transmitters 
in the autonomic and peripheral nervous system. Because of 
the anatomical complexity of the mammalian CNS and because 
amino acids have general metabolic functions in addition to 
any transmitter role, investigations are complicated by 
experimental difficulties which necessitate compromise in the 
rigid application of this 'check-list'.
The first section of this thesis describes work 
on the inhibitory amino acid transmitters, GABA and glycine.
A major part represents the application of several 
neurochemical correlates of synaptically active amino acids, 
including high affinity sodium-dependent uptake, potassium- 
stimulated, calcium-dependent release from brain slices 
and antagonism of post-synaptic action by systematically 
administered drugs, to the problem of the stage during 
postnatal development in the rat at which glycine and GABA 
are first used as transmitters. The second section reports 
neurochemical studies on aspartic acid, with particular 
emphasis on the D-isomer of the natural L-aspartate transmitter.
PART ONE: GLYCINE AND y-AMINOBUTYRIC ACID
I I .  SERINE HYDROXYMETHYLTRANSFERASE IN THE CAT AND
RAT CENTRAL NERVOUS SYSTEM
41. INTRODUCTION
Electrophoretic studies of CURTIS & WATKINS (I960, 
1961) showed the rapid and reversible depressant action of 
glycine on spinal neurones. The high levels of glycine in 
the ventral horn of the spinal cord, together with the 
comparatively low content in the ventral root fibres (APRISON 
& WERMAN, 1965; GRAHAM, SHANK, WERMAN & APRISON, 1967) 
suggested an association between glycine and spinal inhibitory 
interneurones. The proposition that glycine was the 
transmitter released by these neurones gained support from a 
correlation between the decreased levels of glycine in the 
dorsal and ventral grey matter and the loss of interneurones 
after aortic occlusion (DAVIDOFF, GRAHAM, SHANK, WERMAN & 
APRISON, 1966; DAVIDOFF, SHANK, GRAHAM, APRISON & WERMAN,
1967). The levels of Y-aminobutyric acid (GABA), an amino 
acid which also had a depressant action when applied 
microelectrophoretically to spinal neurones and which was 
more concentrated in the dorsal grey matter than in the 
ventral grey matter, were not significantly affected by 
this operation.
The accumulated evidence that glycine is a major 
inhibitory transmitter in certain areas of the mammalian 
central nervous system, including the spinal cord and 
medulla oblongata, has been well documented (APRISON, DAVIDOFF 
& WERMAN, 1970; CURTIS & JOHNSTON, 1970). The major 
pathways whereby glycine is metabolized in nervous tissue 
are, however, still unknown.
The enzyme serine hydroxymethyltransferase (L-serine-
tetrahydrofolate 5, 10-hydroxymethy.ltransferase, EC 2.1.2.1)
which catalyses the interconversion of serine and glycine,
5 10SERINE + TETRAHYDROFOLATES GLYCINE + N N -METHYLENE
TETRAHYDROFOLATE + H O
5has been purified from bovine brain (BRODERICK, CANDLAND, 
NORTH & MANGUM, 1972) and there is evidence to suggest that 
the enzyme plays an important role in glycine metabolism 
(SHANK & APRISON, 1970; SHANK, APRISON & BAXTER, 1973).
The observation that glycine levels vary from 
one CNS region to another (APRISON & WERMAN, 1965; SHAW 
& HEINE, 1965; SHANK & APRISON, 1970) suggested that the 
regional distribution of serine hydroxymethyltransferase 
activity might reveal important information about the 
possible role of this activity in glycine metabolism.
The regional and subcellular distribution of serine 
hydroxymethyltransferase in extracts of rat and cat central 
nervous tissue was investigated. Some structural analogues 
of glycine and serine and various centrally-active drugs 
were tested as potential inhibitors of serine hydroxymethyl­
transferase activity.
2. METHODS AND MATERIALS
Tissue preparation and extraction. Adult Wistar rats 
(150-200g) were killed by decapitation, the brains and 
spinal cords rapidly removed and chilled, and the various 
regions quickly separated. Each brain was divided into 
the following regions: cerebral cortex, midbrain (including
the diencephalon and mesencephalon), cerebellum and 
pons-medulla. The spinal cords were freed from spinal 
roots and the dura removed before homogenization. For 
cat spinal cord segments, the lumbosacral spinal cord was 
removed from cats (4-5 kg) under pentobarbitone anaesthesia 
and cut transversely into 4-6 mm pieces. Individual segments 
were placed on a freezing microtome stage (Pelcool, MSE, 
London) and sectioned into the following regions; dorsal 
white, ventral white, dorsal grey and ventral grey. The 
tissue samples were then weighed and homogenized in 0.1 M
6potassium phosphate buffer (pH 7.4) containing 0.1 w/v Triton 
X-100 (to solubilize membrane-bound and occluded enzyme),
2mM EDTA (to limit the action of divalent-cation dependent 
proteases) and O.lmM dithiothreitol (to stabilize the enzyme 
against oxidation during homogenization and dialysis). The 10% 
w/v homogenates were dialysed for 5 h against several changes 
of phosphate buffer containing EDTA and dithiothreitol, to 
remove endogenous glycine and serine. No loss of activity 
was observed after 16 h of dialysis. It is not knov/n whether 
pentobarbitone anaesthesia has any effect on glycine levels 
or the activities of its metabolising enzymes in the spinal 
cord.
Protein concentrations in the tissue extracts were 
measured by the biuret method (GORNALL, BARDAWILL & DAVID,
1949) or the method of LOWRY, ROSEBROUGH, FARR & RANDALL,
1951), removing lipid by ether extraction immediately prior 
to reading in the spectrophotometer.
Assay of hydroxymethyltransferase activity. The rate of pro­
duction of radioactive formaldehyde from radioactive serine 
was assayed by the method of TAYLOR & WEISSBACH (1965) . The 
reaction mixtures contained 0.5 mM [3-^c] serine, 0.5 mM pyridoxal 
phosphate, 2 mM tetrahydrofolate and 4 mM dithiothreitol in 
100 mM potassium phosphate buffer (pH 7.4) in a final volume 
of 2 ml. Reactions, carried out at 37°C in a shaking water 
bath, were initiated by the addition of 0.5 ml of extract.
At various times 0.4 ml aliquots were removed, and reaction 
terminated by addition to a mixture of 0.3 ml of 1 M sodium 
acetate solution (pH 4.5) and 0.2 ml of 0.1 M formaldehyde.
The P^c]formaldehyde, formed during the reaction, was trapped 
with dimedone, extracted into toluene and counted in a toluene- 
based scintillator (0.01% w/v 1, 4-di-2-(phenyloxayolyl) 
benzene and 0.4% 2, 5-diphenyloxazole in toluene) (see Appendix 
I). The enzyme activities measured in this way were linear for 
at least 40 min. Each assay provided four time aliquots and the 
rate of production of formaldehyde was calculated from the slope 
of the line of best fit through a plot of radioactivity 
versus time, by a least squares analysis using a PDP-8L computer.
7Subcellular distribubion of serine hydroxymethyl transferase. 
Tissue was removed as described and homogenized in 0.32 M 
sucrose at a concentration of 10% w/v using a stainless 
steel mortar and Perspex pestle (rotating at 870 rev/min. 
clearance 0.25 mm difference in diameter). Subcellular 
fractions were prepared by differential and density gradient 
centrifugation as described by JOHNSTON, VITALI & ALEXANDER 
(1970), with the exception that the A^ myelin layer and the 
upper layer were not separated prior to the next 
centrifugation. Pellets were resuspended in phosphate 
buffer containing EDTA and dithiothreitol and dialysed 
overnight against several changes of this buffer. The 
soluble fraction was concentrated prior to assay in an 
ultrafiltration apparatus (Amicon, UM-10 Diaflo ultrafilters).
Chemicals. 5-Azaindole was the gift of Professor A. Albert 
(Canberra), and 0-glycyl-L-serine the gift of Dr J.R. Dice 
(Parke Davis, Detroit). Tetrahydrofolate was prepared by 
Dr G.A.R. Johnston from folic acid by catalytic hydrogenation 
as described by HATEFI, TALBERT, OSBORN & HUENNEKENS (1960). 
Hydrazinoacetic acid was prepared by published procedures 
(CARMI, POLLAK & YELLIN, 1960; DODGSON, LLOYD & TUDBALL,
1961).
14L-[3- C]Serine, specific activity 48 mCi/mmole,
was purchased from the Radiochemical Centre, Amersham.
14The specificity of the [ c] label was checked by sodium 
periodate oxidation of the radioactive serine. Other 
chemicals were purchased as follows: amino-oxyacetic acid,
3-mercaptopropionic acid and thiocarbohydrazide (Eastman); 
DL-C-allylglycine, D-cycloserine and pyridoxal phosphate 
(Sigma); 5-aminotetrazole, dimedone, kojic acid, and 
L-serine (Fluka); thiosemicarbazide and L-threonine 
(B.D.H.); glycine and sucrose (Mann); aminopterin and
BDL-2-methylserine (Calbiochem); N-acetylglycine (Light);
DL-3-phenylserine (Nutritional Biochemical Corp.) and 
strychnine (T. and M. Smith).
3. RESULTS
The regional distribution of serine hydroxymethyl- 
transferase activity in the extracts of rat central nervous 
tissue is presented in Table 2.1# together with the 
concentrations of glycine and serine in the various regions 
as determined by SHANK & APRISON (1970). No significant 
differences in enzymic activity were observed between the 
five regions examined, whereas the concentrations of both 
glycine and serine show appreciable variation.
The distribution of serine hydroxymethyltransferase 
activity in the four regions of cat spinal cord is given in 
Table 2.2, together with the distribution of glycine and 
serine as determined by JOHNSTON (1968). The values for 
activity in extracts of grey matter are almost double those 
in white matter. Activity in the ventral grey matter extracts 
is significantly higher than in the dorsal grey matter 
extracts at P< 0.05 based on wet weight of tissue, and at 
P < 0.025 based on protein, using Student's t-test.
The subcellular distribution of serine hydroxymethyl 
transferase activity in homogenates of rat cerebral cortex 
and spinal cord was very similar (Table 2.3). Activity 
was concentrated in the mitochondrial, soluble and nuclear 
fractions. The activity observed in the nuclear fraction 
may be due to contamination with mitochondria and unbroken 
cells and thus no definite conclusion can be drawn as to 
the occurrence of the enzyme in or associated with nuclei.
Under the experimental conditions used, a number 
of substances significantly inhibited the serine
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9hydroxymethyltransferase activity in extracts of rat spinal 
cord (Table 2.4), the most effective being hydrazinoacetic 
acid, t'hiocarbohydrazide, amino-oxyacetic acid and cycloserine.
4. DISCUSSION
No significant differences were found in the 
serine hydroxymethyltransferase activity in extracts of 
various regions of the rat central nervous system. As there 
are regional differences in serine and glycine content, it 
seems from these results that serine hydroxymethyltransferase 
is not rate determining with respect to either glycine or 
serine metabolism. The rate controlling step for the 
formation of glycine from glucose may be the conversion of 
D-glycerate to hydroxypyruvate, catalysed by D-glycerate 
dehydrogenase (see Fig. 2.1), since the enzyme from rat brain 
is inhibited by glycine in a non-competitive manner 
suggestive of end product inhibition (UHR & SNEDDONt 1971) 
and, in the cat at least, its activity correlates with 
the regional distribution of glycine (UHR & SNEDDON, 1972).
An attempt was made to measure the activities of D-glycerate 
dehydrogenase and 3-phosphoglycerate dehydrogenase in five 
regions of the rat CNSy although both activities were present 
in extracts of all regions examined including cerebral 
cortex, midbrain (diencephalon and mesencephalon), cerebellum, 
pons-medulla and spinal cord, the formation of NADH was not 
linear with time and activities were not quantified.
A recent report (DALY & APRISON, 1974) has measured 
serine hydroxymethyltransferase in five regions of rat 
brain. Utilizing somewhat different conditions and 
concentrations of substrate and cofactors, they found the 
levels in the telencephalon and midbrain to be approximately 
three-quarters of the levels in cerebellum, pons-medulla 
and spinal cord. When these values were expressed per
Table 2.4. Inhibitors of serine hydroxymethyltransferase 
activity in extracts of adult rat spinal cord
Inhibitor (0.5 mM) % Inhibition
Hydrazinoacetic acid 
Thiocarbohydrazide 
Amino-oxyacetic acid 
D-Cycloserine 
Thiosemicarbazide 
O-Glycyl-L-serine 
Aminopterin 
N-Acetylglycine 
DL-Serine-O-sulphate 
Kojic acid
3-Mercaptopropionic acid 
Threonine 
DL-2-Methylserine 
Nikethamide
94
93
83
76
49
37
30
22
21
20
17
15
13
5
+
+
+
+
+
+
+
+
+
+
+
+
8
4
1
2
2
2
4
2
3
2
2
1
1
No significant inhibition: DL-C-allylglycine, 5-aminotetrazole,
5-azaindole, DL-3-phenylserine, strychnine
Values are means - S.E.M. of three determinations. Inhibitors 
were tested in the standard assay.
Fig. 2.1. Possible routes of glycine metabolism in the CNS 
(from CURTIS & JOHNSTON, 1974). Possible routes of glycine 
synthesis from glucose via the 'phosphorylated' and 'non- 
phosphorylated' pathways are given. Not all reactions 
represented here have been shown to occur in the CNS e.g. 
the hydroxypyruvate: a-alanine transaminase is very low or 
absent (dog, ox: WALSH & SALLACH, 1966; rat, cat: UHR,
unpublished results).
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relative number of mitochondria in each region (as estimated by 
measuring the levels of succinate dehydrogenase), there was a 
correlation with glycine levels. The role of serine hydroxy- 
methyltransferase in non-transmitter metabolism (i.e. in the 
supply of folates, active carbons and/or 'metabolic' glycine) 
appears to account for the largest portion of activity measured 
(see Section III.4). The fact that these regional variations 
were not apparent in this study may be due to the fact that the 
concentration of the substrate, serine, used in the assay (0.5 mM 
was of the order of the Michaelis constant for the enzyme 
(K =0.62 mM for the brain enzyme; DALY & APRISON, 1974:
= 0.54 mM for liver enzyme? NAKANA, FUJIOKA & WADA, 1968) 
and thus activity measured was only about half of that possible 
with saturating serine concentrations. Significant regional 
differences might have been more readily observed had maximal 
in vitro activities been obtained by the use of saturating 
serine concentrations (e.g. 4 mM).
Serine hydroxymethyltransferase, like other amino 
acid metabolizing enzymes including D-amino acid oxidase 
(DeMARCHI & JOHNSTON, 1969), glutamine synthetase, glutaminase, 
GABA:2-oxoglutarate aminotransferase, aspartate:2-oxoglutarate 
aminotransferase, glutamate decarboxylase, glutamate de­
hydrogenase (GRAHAM & APRISON, 1969) and glycine:2-oxoglutarate 
aminotransferase (JOHNSTON, VITALI & ALEXANDER, 1970), was found 
to be more concentrated in the grey matter than in white matter 
of cat spinal cord. Serine hydroxymethyltransferase and glutamate 
decarboxylase (GRAHAM & APRISON, 1969) are the only ones to 
show dorsoventral differences within the spinal grey matter. 
Serine hydroxymethyltransferase and glycine are more concentrated 
in the ventral grey matter than in dorsal grey matter, while 
the reverse is true for glutamate decarboxylase, glutamate 
and GABA. Dorsoventral differences in enzymic activity were 
not apparent in the white matter, whereas glycine is more con­
centrated in the ventral than in dorsal regions of both the 
grey and white matter (APRISON & WERMAN, 1965; JOHNSTON, 1968) . 
The correlation coefficient for the hydroxymethyltransferase 
activity (per mg protein) when compared with glycine levels in
11
in the four regions (JOHNSTON, 1968) was 0.90.
Under the assay conditions employed, the measured 
rate of glycine production from serine by the hydroxymethyl- 
transferase activity in the cat spinal cord extracts was of 
similar order to the rate of glycine production from glyoxylate 
by glycine:2-oxoglutarate activity in extracts of the same 
regions (JOHNSTON, VITALI & ALEXANDER, 1970). The activities 
are fairly low in comparison with many other amino acid metaboli­
sing enzymes, but in as much as enzyme activities measured 
in vitro can be related to those in vivo, they appear to be 
quite adequate to account for the estimated rates of glycine 
and serine formation from glucose in vivo (SHANK & APRISON,
1970) .
The subcellular distribution of hydroxymethyltrans- 
ferase activity was at least bimodal in the homogenates of rat 
cerebral cortex and spinal cord, being concentrated in the 
mitochondrial and soluble fractions. A similar subcellular 
distribution has been found in homogenates of rat liver 
(NAKANO, FJUIOKA & WADA, 1968). No differences were observed in 
the subcellular distribution of hydroxymethyltransferase acti­
vity in the cerebral cortex, where glycine is unlikely to be 
a synaptic transmitter, and in the spinal cord, where a trans­
mitter role is highly probable. These findings provide no 
evidence to suggest that this enzyme is specifically associated 
with synaptosomes produced on homogenization of nerve endings 
which released glycine as a transmitter.
However, the total enzyme activities recovered in the 
subcellular fractionation study were low compared with the acti­
vity in Triton X-100 treated homogenates (about 30% for rat 
cortex; Table 2.3 c.f. Tables 2.1) because these fractions were 
assayed in the absence of the detergent. Thus particulate 
enzyme was not fully accessible to substrates during the enzyme 
assay. This would result in underestimation of the enzyme 
activity in particulate fractions and on the basis of the
12
percentage recoveries of activites, lead to an overestimate of 
the proportion of enzyme in the soluble fraction.
Subfractionation of five brain regions by DALY & APRISON (1974) 
and subsequent assay in the presence of Triton X-100 showed 
that between 50-63% of the recovered enzyme activity was in 
the crude mitochondrial pellet (mitochondria, synaptosomes 
and myelin) and only 1-4% in the soluble fraction. Further 
fractionation of the crude mitochondrial pellet showed that 
77-82% of recovered activity was in the mitochondria and 
10-19% in the synaptosomal fraction. RASSIN & GAULL (1975) 
found 74% of serine hydroxymethyltransferase activity in the 
crude mitochondrial fraction and 5% in soluble form. Sub­
fractionation of the crude mitochondrial fraction showed that 
78% was in mitochondria and 15% in synaptosomes. Thus the enzyme 
is essentially mitochondrial in nature. It is interesting to 
note that further results of RASSIN & GAULL (1975) suggest that 
the enzyme is not associated to any great degree with those 
mitochondria that are present in synaptosomes. McBRIDE, DALY & 
APRISON (1974) found no obvious correlation between the rate 
of conversion of serine to glycine by crude synaptosomal pellets 
(containing myelinated axons, synaptosomes and mitochondria) 
prepared from the spinal cord, medulla oblongata, telencephalon 
and cerebellum of the rat and the levels of glycine measured 
in the same areas.
Most of the substances found to inhibit serine 
hydroxymethyltransferase activity in extracts of rat spinal 
cord are known to inhibit other pyridoxal-dependent enzymes 
(hydrazinoacetic acid, thiosemicarbazide, thiocarbohydrazide, 
amino-oxyacetic acid, D-cycloserine, 3-mercaptopropionic 
acid) and/or are structural analogues of glycine and serine 
(hydrazinoacetic acid, amino-oxyacetic acid, D-cycloserine, 
0-glycy1-L-serine, N-acetylglycine, DL-serine-O-sulphate, 
L-threonine, DL-2-methylserine). The inhibitors include cer­
tain convulsants (thiocarbohydrazide, thiosemicarbazide, kojic 
acid, 3-mercaptopropionic acid) whereas other convulsants 
(DL-C-allylglycine, 5-azaindole and strychnine) had no effect 
on hydroxymethyltransferase activity. Glycine levels in rat 
cerebellum are known to be reduced during convulsions induced
13
by 3-mercaptopropionic acid. Inhibition of serine hvdroxy- 
methyltransferase may contribute to this reduction in glycine 
level.
Suckling rats, whose mothers were fed on vitamin 
Bg-deficient diet from parturition, had levels of pyridoxal 
phosphate which were reduced by two-thirds when compared with 
control animals. Analysis of amino acids in these animals 
at 19 days postnatal age (KURTZ, LEVY & KANFER, 1972) showed 
large changes in levels. Of these, glycine levels were in­
creased nearly three times, while serine levels were reduced 
by one-quarter. These changes may in part reflect diminished 
activity of serine hydroxymethyltransferase, although studies* 
of its activity in pyridoxine-deficient rats have not been 
reported.
In conclusion, these studies did not show any corre­
lation between the activity of serine hydroxymethyltransferase 
in extracts prepared from different regions of the rat CNS and 
the glycine or serine content of those regions. On the basis 
of in vivo studies using radioactive glucose SHANK & APRISON 
(1970) suggested that glycine appeared to be derived predomi­
nantly by de novo synthesis from glucose through serine, but that 
there appeared to be no correlation between the content of 
glycine and its rate of synthesis from serine. Within the cat 
spinal cord, some degree of correlation between glycine levels 
and hydroxymethyltransferase was apparent, with higher levels 
of both in ventral as compared with dorsal grey matter. In view 
of this finding, it would be worthwhile to do regional and sub- 
cellular distribution studies of serine hydroxymethyltransferase 
in feline CNS, particularly since larger amounts of CNS tissue 
are available from cats than from rats. These studies were not 
done because of the difficulty at that time of obtaining animals. 
Subcellular distribution studies on rat brain cerebral cortex 
and spinal cord reported here suggest that the enzyme is located 
predominantly in the mitochondria, and to a lesser extent, the 
cytoplasm.
Data showing levels of this enzyme in rat CNS at severa. 
stages postnatally is presented in the following chapter.
III. POSTNATAL CHANGES IN THE LEVELS OF GLYCINE AND 
THE ACTIVITIES OF SERINE HYDROXYMETHYLTRANSFERASE 
AND GLYCINE:2-OXOGLUTARATE AMINOTRANSFERASE
IN THE RAT CENTRAL NERVOUS SYSTEM
14
1. INTRODUCTION
In general* the mammalian brain shows a caudal- 
rostral development, with spinal cord systems maturing 
morphologically, biochemically and functionally earlier than 
higher CNS centres (TIMIRAS, VERNADAKIS & SHERWOOD, 1968) .
The rat is a good choice for developmental studies because 
the brain is comparatively immature at birth, undergoes a 
period of accelerated growth during the first three postnatal 
weeks and reaches maturity at completion of myelination in 
about 60 days (VERNADAKIS & WOODBURY, 1969).
Using an ethanolic-phosphotungstic acid (E-PTA) 
stain which renders morphologically specialized junctions 
electron-opaque (BLOOM & AGHAJANIAN, 1966), the formation 
of synaptic junctions has been followed in rat parietal 
cortex molecular layer (AGHAJANIAN & BLOOM, 1967) and in 
cerebellar cortex molecular layer (folia VII and VIII; 
WOODWARD, HOFFER, SIGGINS & BLOOM, 1971). Few E-PTA staining 
synaptic junctions are evident in the molecular layer of 
cortex on the 12th or 13th postnatal day, but between the 
14th and 26th day there is a rapid increase to normal 
adult levels. In the molecular layer of the cerebellar 
folia VII and VIII, the latest folia to mature, synapses 
are first evident at day three, with an increase in two 
or more slow phases, reaching near adult levels by the 
end of the third postnatal week. There appears to be a 
close relationship between morphological development and 
development of electrical activity.
Electron-microscopic observations on synaptic 
development in foetal rat lumbar spinal cord (MAY & BISCOE, 
1973) have shown the appearance of axodendritic and 
axosomatic synapses over foetal days 14-18 (gestation 
period is 21 days). The appearance of these immature
15
synapses correlates with observed changes in the mobility 
of the foetus, as foetal movements begin during this period.
As well as adding to knowledge of brain development, 
neurochemical studies of developmental changes can provide 
a useful variable which may lead to the better understanding 
of certain aspects of mature brain function. For both 
reasons, the developmental studies presented in the following 
three chapters were performed. Firstly, an examination 
of levels of serine hydroxymethyltransferase and glycine: 
2-oxoglutarate aminotransferase was carried out at several 
stages of development in an attempt to clarify their roles 
in the maintenance of different regional glycine levels. 
Furthermore, the time during ontogenetic development when 
glycine and GABA are first used as inhibitory transmitters 
was of interest, in view of the fact that their inhibitory 
transmitter function in the adult mammalian CNS is relatively 
well established.
Following the suggestion of APRISON & WERMAN 
(1965) that glycine was a likely inhibitory transmitter 
released by some spinal interneurons, it was found that 
glycine levels in the medulla oblongata and spinal cord 
of five mammalian species were 3-5 times higher than the 
levels in supra-medullary structures and cerebellum 
(APRISON, SHANK, DAVIDOFF & WERMAN, 1968). This increasing 
rostro-caudal gradient was most evident in cat and rat.
As an initial approach to the problem of glycine 
neutrotransmitter development, therefore, the regional 
distribution of glycine was determined in 10-day-old animals. 
In addition, levels of other amino acids were quantified; 
nearly all studies on the developmental pattern of amino 
acid levels in the mammalian CNS have been confined to 
whole brain levels rather than a number of discrete regions, 
while spinal cord tissue has been little studied.
15a
For the following studies, rats of 1 day, 10 days and 
13 weeks postnatal age were used. The brains of 1-day-old rats 
are quite immature and represent a convenient stage at which 
tissue can be quickly and conveniently removed and dissected 
into the following regions; cerebral hemispheres, cerebellum, 
midbrain and pons-medulla. The brains of 10-day-old rats are 
undergoing a weight growth 'spurt' (see DISCUSSION) and are at 
a stage, just prior to the onset of myelination, when differenti­
ation of neuronal and glial cell types has taken place in much 
of the brain, and neuronal cell processes have proliferated 
extensively. Thus during the period from birth to 10 days 
the rat CNS undergoes extensive maturation, although in most 
regions apart from the cerebellum there is little increase in 
the total cell numbers over this time. Thirteen-week-old animals 
were taken to represent a mature stage of brain development.
These 'young adults' have obtained about 80% of their maximum 
body weight (DOBBING, 1968) and from an anatomical point of 
view, have a mature CNS (ADINOLFI, 1971). 'Young adults' at 
about this stage of development are commonly used for bio­
chemical studies.
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2. METHODS AND MATERIALS
Tissue preparation and extraction. Wistar rats of 1 day,
10 days or 13 weeks postnatal age were killed by decapitation. 
Removal of CNS tissue, separation into regions and homogeni­
zation in buffer was carried out as described (Section II.2). 
For amino acid analysis, the tissue (100-500 mg wet weight) 
was homogenized in 2 ml of ice-cold 1% aqueous picric acid 
with a glass-teflon homogenizer. The homogenate was allowed 
to stand for 30 min at 0°C and sufficient Dowex 2 x 10 resin 
(chloride form^ 200-400 mesh) added to discharge the 
yellow colour. The resin was sedimented by centrifugation, 
washed with 2 x 10 ml volumes of 0.02 M hydrochloric acid, 
and the combined supernatant and washings evaporated to 
dryness in vacuo. The residue was dissolved in a known 
volume of pH 2.2 citrate buffer, centrifuged (27,000g for 
10 min) to remove any particulate matter and the supernatant 
fluid analysed on a modified Technicon Auto Analyser (JAMES, 
1972), using the two-buffer system of SPACKMAN, STEIN &
MOORE (1958). ß-Thienylalanine and a-amino- ß - 
guanidinopropionic acid were added to the initial picric 
acid homogenates to act as internal standards for the 
recovery of the natural amino acids.
Assay of Serine hydroxymethyltransferase. This enzyme was 
assayed as described previously (Section II.2).
Assay of Glycine:2-oxoglutarate aminotransferase. Enzymic
formation of radioactive glycine from [2-^c] glyoxylate
and L-glutamate was assayed essentially as described
previously (JOHNSTON & VITALI, 1969) by incubating 0.5 ml
samples of CNS extract with 0.5 ml of a solution of 60 
14mM [2- c]glyoxylate and 5 mM EDTA, adjusted to pH 7.4 
with NaOH, 0.5 ml of 20 mM monosodium L-glutamate and 
0.5 ml of 100 mM potassium phosphate buffer, pH 7.4, at
17
37°C in a shaking water bath. At various times, 0.4 ml 
samples were removed and chromatographed on columns 
(7 x 50 mm) of Dowex 1 x 8  resin (acetate form; 100-200 
mesh), eluting with distilled water. The first 5 ml of 
eluent from each column was collected and its radioactivity 
determined by liquid scintillation using 1 ml samples in 
10 ml of dioxan-based scintillator (0.5% (w/v) 2,5-diphenyl* 
oxazole and 10% (w/v) naphthalene in Dioxan). These columns 
retained more than 99% of radioactive glyoxylate.
Chemicals. 3 -Thienylalanine and a-amino- 3-guanidinopropionic
acid were purchased from Pierce Biochemicals. The source 
of other chemicals used has been given (Section II.2).
3. RESULTS
Amino acid levels. The levels of amino acids in five 
regions of the CNS of 10-day rats are given in Table 3.1.
As in the adult rat and cat (APRISON, SHANK, DAVIDOFF & 
WERMAN, 1968), glycine is present in higher concentrations 
in the spinal cord and pons-medulla than in higher brain 
regions. In fact, glycine is the only amino acid found 
in significantly higher concentration in the spinal cord than 
in any other CNS region of the 10-day-old rats. Spinal 
amino acid levels from 1-day, 10-day and 13-week-old rats 
are shown in Table 3.2. The glycine content of spinal 
cord from 1- and 10-day animals did not differ significantly 
from that of adult cord.
As observed for whole brain (BAYER & McMURRAY,
1967; AGRAWAL, DAVIS & HIMWICH, 1966) the spinal levels of 
taurine, serine, proline, a-alanine, valine, leucine, 
tyrosine, phenylalanine and histidine decreased with 
increasing age, while the level of aspartate increased, 
and the levels of lysine, isoleucine and cystathionine showed
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Table 3.2. Amino acid levels, expressed as Mmol/g wet 
tissue, in extracts of spinal cord from 
rats of different ages
Amino acid
1 day
Postnatal Age 
10 days 13 weeks
Taurine 9.97 + 0.95 4.90 + 0.42 1.30 + 0.05
Aspartate 1.22 -f* 0.08 1.63 + 0.10 1.83 + 0.11
Serine 0.72 + 0.08 0.77 + 0.13 0.46 + 0.12
Glutamine 5.82 + 0.09 4.76 -l- 0.51 2.34 4 - 0.39
Proline 0.56 + 0.10 0.39 + 0.05 0.09 + 0.03
Glutamate 4.52 + 0.51 3.06 + 0.18 3.67 + 0.31
Glycine 3.98 + 0.52 3.22 + 0.33 3.22 + 0.17
ot-Alanine 2.73 + 0.97 1.93 + 0.48 0.45 + 0.22
Valine 0.31 + 0.11 0.15 + 0.03 0.07 + 0.01
Cystathionine 0.31 + 0.02 0.34 + 0.05 0.30 + 0.02
Isoleucine 0.18 + 0.03 0.14 + 0.01 0.15 -I- 0.05
Leucine 0.27 + 0.03 0.19 + 0.03 0.11 + 0.03
Tyrosine 0.28 + 0.03 0.37 + 0.05 0.08 + 0.01
Phenylalanine 0.10 + 0.01 0.10 + 0.02 0.03
GABA 1.15 + 0.20 1.59 + 0.23 0.80 + 0.10
Lysine 0.73 + 0.11 0.65 + 0.03 0.88 + 0.07
Histidine 0.61 + 0.13 0.39 + 0.05 0.08 + 0.01
Values are means - S.E.M. of 3 - 5 determinations, unless
individual values are given. Because of the lack of 
separation between the serine and glutamine peaks in the 
system used, the values given for serine are only approximate.
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no significant change. In contrast to findings for rat 
brain however, the spinal levels of glutamate, glutamine 
and GABA decreased.
Turning to brain, a comparison of the regional 
levels in 10-day-cld rats (Table 3.1) with those reported 
by KÄNDERA, LEVI & LAJTHA (1968) for adult rats (Data reproduced 
in Table 3.1a), shews that for all brain regions there is 
a developmental decrease in the levels of taurine, valine, 
cystathionine, isoleucine, leucine, tyrosine, phenylalanine, 
lysine and histidine and an increase in the levels of 
aspartate and glutamate. The level of GABA increased in 
all regions except the midbrain, whereas that of <X-alanine 
decreased in all regions except the pons-meäulla. The 
glycine level decreased in all brain regions except the 
pons-medulla where the level increased. There appeared 
to be little change in the serine level in any brain region, 
in agreement with studies on whole brain development 
(BAYER & McMURRAY, 1967; AGRAWAL, DAVIS & HIMWICH, 1966).
The levels of cx-alanine showed greater regional 
variation in 10-day-old rats than in adults. The midbrain 
level of -alanine in 10-day-old rats is very high compared 
with adult levels and varied over a wide range in the five 
animals examined. The level of GABA in the midbrain in 
10-day-old rats is higher than in the other CNS regions, 
as is the case for adult rats (KANDERA, LEVI & LAJTHA,
1968).
A decreasing rostrocaudal gradient was very 
apparent for taurine in the 10-day-old rats, with levels 
ranging from 14.7 pmol/g in the cerebral cortex to 
4.9 pmol/g in the cord. A similar pattern occurs in adult 
rats where levels decrease from 7.6 pmol/g in the cerebral
19
cortex to 2.0 pmol/g in the pons-medulla (KANDERA, LEVI &
LAJTHA, 1968) and 1.3 ;amol/g in spinal cord. The decrease 
in taurine levels in all regions is very marked and suggests 
that taurine may play an important role during the 
development of the CNS (AGRAWAL, DAVISON & KACZMAREK, 1971; 
KACZMAREK, AGRAWAL & DAVISON, 1971).
Serine hydroxymethyltransferase activity. The regional 
distribution of serine hydroxymethyltransferase activity 
in extracts of CNS tissue from rats of different postnatal 
ages (1-day, 10-day and 13-week) is shown in Table 3.3.
There is a decrease in activity of the enzyme from newborn 
to adult rats. The highest levels of activity were found 
in extracts of the cerebellum of the 10-day-old rats.
The effects of a number of inhibitors on this activity 
(Table 3.4) were similar, but not identical to those observed 
on the hydroxymethyltransferase activity in extracts of 
adult spinal cord (Table 2.4).
Glycine:2-oxoglutarate aminotransferase activity. The data 
obtained for the regional distribution of glycine: 
2-oxoglutarate activity (Table 3.5) suggest a slightly 
greater activity in 10-day-old than 1-day-old animals. 
Activities measured in four brain regions in adult rats 
have shown that levels in cerebral grey matter and the 
midbrain are the same . Slightly higher levels are found in 
the corpus callosum and the lowest levels are in the spinal 
cord (BENUCK, STERN & LAJTHA, 1972).
4. DISCUSSION
From a regional comparison of glycine levels in 
10-day-old rats, it is apparent that the increasing 
rostrocaudal gradient so prominent in adults (Table 2.1) 
is established in young rats at least as early as ten days
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Table 3.4. Inhibitors of serine hydroxymethyltransferase 
activity in extracts of 10-day-old rat cerebellum
Inhibitor 0.5 mM % Inhibition
Aminooxyacetic acid
Thiosemicarbazide
O-Glycyl-L-serine
L-Serine-O-phosphate
DL-Serine-0-sulphate
L-Threonine
Aminopterin
Strychnine
3-Phenylserine
Kojic acid
DL-2-Methylserine
No significant inhibition;
95.8 + 0.1
61.5 + 0.1
48.9 + 0.3
25.9 + 0.2
21.3 + 0.3
23.7 + 0.5
23.3 + 0.3
16.2 + 0.2
16.1 + 0.3
11.8 + 0.2
9.5 + 0.2
allylglycine, 5 aminotetrazoleDL-C-
Values are expressed as % inhibition and are means - S.E.M. 
of four determinations. Inhibitors were tested in the 
standard assay.
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after birth. The present study shows that the overall 
developmental changes in amino acids in the different brain 
regions are consistent with developmental changes of total 
brain amino acids (HIMWICH & AGRAWAL, 1969; AGRAWAL, DAVIS & 
HIMWICH, 1966; BAYER & McMURRAY, 1967; DAVIS & HIMWICH, 1973) 
with the exception of glycine in the pons-medulla which is 
lower in 10-day-old rats than in the adults. In the spinal 
cord a somewhat different developmental pattern from that of 
higher brain regions is observed in that only aspartate, and 
not glutamate or GABA, increased during development.
The levels of isoleucine, cystathionine and lysine showed no 
change. Glycine showed no significant decrease, while the 
level of all other amino acids decreased.
There is no correlation of either serine 
hydroxymethyltransferase activity or glycine:2-oxoglutarate 
aminotransferase activity with glycine levels in the CNS of 
10-day-old rats. There is however, a general decrease in 
the measured activity of the hydroxymethyltransferase with 
development, which is in contrast to many other enzymes 
which increase in activity as the brain matures. This finding 
is in agreement with that of BRIDGERS (1968), who found 
that the activity was highest in new-born mouse brain and 
then declined to reach a steady level between two and three 
weeks postnatal age. BRIDGERS (1968) suggested that 
hydroxymethyltransferase activity essentally paralleled the 
growth rate of neonatal mouse brain. The present results in 
rat CNS, especially in the cerebellum, support this suggestion.
A growth 'spurt' or period in which there is a marked 
increase in the rate of gain of weight, occurs in the ontogenetic 
development of mammalian brain (DAVISON & DOBBING, 1968). In 
the rat this growth peak is maximal at 11 days after birth 
and is due mainly to cerebellar development. There is a twenty­
fold growth in the cerebellum between 1-21 days (measured as 
increase in area of saggittal sections), primarily due to 
development of the cortex (ALTMAN, 1969). The addition of 
new cells accelerates rapidly in the first week of postnatal
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life and it remains at a high level until about the end of 
the second week (ALTMAN, 1966). However, the rate of growth 
of other regions declines from birth. Estimates of cell 
proliferation, as measured by in vitro DNA synthesis have been 
reported by SUNG (1968) . The following activities (mpmol 
[2-^c] thymidine incorp. into DNA/g tissue/h) were recorded 
in six regions; cerebral cortex (1.27), cerebellum (23,9), 
midbrain (0.78), pons-medulla (1.09), olfactory bulb (2.50) 
and hypothalamus (0.74). Further results show that the activity 
remains high in the cerebellum until 6-10 days after birth 
before decreasing, whereas activity in the cerebral cortex 
decreases from birth.
Ornithine decarboxylase is an enzyme involved in 
the synthesis of spermine and spermidine, polyamines which 
probably have an important function during cell growth.
The levels of this enzyme in the rat cerebrum, cerebellum 
and brainstem have been shown to parallel those periods of 
maximal cell proliferation (ANDERSON & SCHANBERG, 1972).
The level in the cerebellum increases from birth to a maximum 
at ten days then decreases, whereas activity in the cerebrum 
decreases from birth almost to the adult level by the twelfth 
postnatal day. This pattern is much the same for serine 
hydroxymethyltransferase (Table 3.3). If serine hydroxy- 
methyltransferase levels in cerebrum and cerebellum at three 
stages of development, 1-day, 10-days and 13 weeks postnatal age 
are compared with the levels of ornithine decarboxylase 
measured in the same regions at 1-day, 10-days and 12 or 15-days 
(when adult values are reached), a correlation coefficient of 
0.96 is obtained. Therefore the results reported here 
suggest that hydroxymethyltransferase levels correlate with 
the growth rate of neonatal rat brain. It appears that the 
major role of this enzyme, during development at least, is in 
the formation of 1-carbon units from the cc-carbon of glycine 
and the ß -carbon of serine, which are used for the bio­
synthesis of thymine and various purines, precursors of DNA 
and RNA.
IV. POSTNATAL CHANGES IN THE HIGH AFFINITY UPTAKE 
OF GABA AND GLYCINE IN THE 
RAT CENTRAL NERVOUS SYSTEM
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1. INTRODUCTION
Carrier-mediated, structurally specific uptake 
systems for glycine and GABA are considered to be extremely 
important in the maintenance of low extracellular levels 
of these amino acids, both as a means of terminating transmitter 
action and of providing transmitter for re-use (CURTIS &
JOHNSTON, 1974). There is no evidence to indicate that 
glycine or GABA is inactivated enzymically in the extracellular 
synaptic environment. The observed inhibition of glycine 
and GABA uptake by p-chloromercuriphenylsulphonate (BALCAR 
& JOHNSTON, 1973) would explain the effect of this mercurial 
in vivo in potentiating and prolonging the depressant 
actions of GABA and glycine on the firing of feline spinal 
interneurons when administered microelectrophoretically 
(CURTIS, DUGGAN & JOHNSTON, 1970).
Much recent neurochemical research has been 
concerned with studying the specificity, kinetics, sensitivity 
to inhibitors, regional distribution and association with 
subcellular particles of the uptake processes for particular 
amino acids using tissue slices, homogenates, subcellular 
fractions and cultured glia and neurons (COHEN & LAJTHA,
1972; SNYDER, LOGAN, BENNETT & ARREGUI, 1973). Structurally 
specific uptake systems fall into two groups on the basis 
of their kinetic parameters, subcellular and regional 
distributions. The first group is characterized by
K s higher than 5 x 10 4 M (SMITH, 1967; BLASBERG, 1968).
m  - 5The second have K s lower than 5 x 10 M and are referredm
to as 'high affinity' uptake systems. Those high affinity 
uptake systems which are sodium-dependent have been found 
to be specific for the amino acids considered most likely 
to be transmitters, GABA, glycine, taurine and L-glutamate/ 
L-aspartate and appear to be associated with distinct populations
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of isolated nerve terminals (synaptosomes). This latter 
observation is based on evidence from autoradiographic 
(BLOOM & IVERSEN, 1971; HÖKFELT 6c LJUNGDAHL, 1971; MATUS & 
DENNISON, 1971) and subcellular fractionation studies 
(IVERSEN 6c SNYDER, I960; IVERSEN & JOHNSTON, 1971; WOFSEY, 
KUHAR 6c SNYDER, 1971; ARREGUI, LOGAN, BENNETT 6c SNYDER,
1972) and suggests that these uptake systems are intimately 
involved in CNS synaptic function by providing a supply of 
transmitter for re-use. In fact, sodium-dependent, high 
affinity uptake into synaptosomes has been proposed as a 
means of identifying amino acid transmitters (BENNETT,
LOGAN 6c SNYDER, 1972; SNYDER, YOUNG, BENNETT 6c MULDER,
1973; BENNETT, MULDER & SNYDER, 1974).
Although synaptosomal uptake appears to be very 
important, glial uptake of neurotransmitter candidates has 
been demonstrated (HENN 6c HAMBURGER, 1971; LJUNGDAHL & 
HÖKFELT, 1973a, b; SCHRIER & THOMPSON, 1974). A possible 
role of central nervous system glial cells could be to ensure 
more rapid or efficient removal of neuronally-released 
transmitter. It is becoming increasingly apparent that 
sodium-dependent high affinity uptake systems for amino 
acids are not necessarily solely related to synaptic 
transmission mediated by these amino acids, since a high 
affinity sodium-dependent GABA uptake has been observed 
in sympathetic ganglia (BOWERY & BROWN, 197 2) , rat dorsal 
root ganglia and autonomic ganglia (YOUNG, BROWN, KELLY & 
SCHON, 1973; SCHON & KELLY, 1974a, 1974b) and in dorsal 
and ventral roots (DAVIES & JOHNSTON, 1974), sites where 
GABA seems to be most unlikely to be important as a 
transmitter. Accumulation in rat sensory ganglia and 
autonomic ganglia was exclusively localized within satellite 
glial cells. However, the rate of uptake of GABA as measured
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by V is very low in roots and ganglia and indicates max
the presence of comparatively few uptake sites. Furthermore 
this high affinity uptake seems to differ with respect 
to inhibitors and substrate specificity from that high 
affinity uptake observed in the CNS (SCHON & KELLY, 1974b).
IVERSEN & BLOOM (1972) have studied the uptake of 
3 3[ H]GABA and [ H]glycine into slices and homogenates of rat
brain and cord by electron microscopic autogradiography.
Using substrate concentrations suitable for examining high
affinity uptake they have demonstrated a predominant
3 3localization of [ h ]GABA and ['ll] glycine over nerve terminals 
of cortex and spinal cord respectively.
The work described in this chapter was undertaken 
to determine if high affinity uptake systems for glycine and 
GABA existed in slices prepared from tissue of young animals, 
and if so, to determine changes with respect to kinetic 
characteristics, sodium-dependence and substrate specificity. 
Experimental conditions chosen for uptake studies were very 
similar to those which have been used to demonstrate high 
affinity glycine and GABA uptake in adult CNS tissue slices 
(IVERSEN & JOHNSTON, 1971; JOHNSTON & IVERSEN, 1971).
2. METHODS AND MATERIALS
Glycine and GABA uptake by tissue slices. The procedures 
used for measuring the uptake of glycine into spinal cord 
slices and of GABA into cerebral cortex slices were 
essentially similar to those described previously (JOHNSTON 
& IVERSEN, 1971; BEART, JOHNSTON & UHR, 1972). Wistar 
rats of 1-day, 10-days and 13-weeks postnatal age were 
used and it was necessary to pool tissue from more than 
one animal as follows: (a) 1-day-old rats, six to nine
animals per experiment, and (b) 10-day-old rats, three to
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six animals per experiment. Tissue was chopped into mini­
slices (0.1 x 0.1 x 1-2 mm) using a Mcllwain tissue chopper 
and immediately suspended in cold buffer (1 ml/100 mg tissue). 
100 yl aliquots (10 mg wet weight of tissue) were dispensed 
into incubation bottles (Kimax 15105-L, 30 ml capacity) 
containing 10 ml of oxygenated buffer. The bottles were 
preincubated for 15 min at 25°C or 37°C (details are given 
in the tables of results) in a shaking water bath, before 
the addition of radioactive substrate (100 yl) and incubation 
continued for a further 10 min. All determinations, including 
blanks (i.e. not incubated) were done in quadruplicate.
Slices were collected by vacuum filtration on filter paper 
circles (Whatman No.l, 23 mm diam). Bottles and filters 
were washed with 10 ml of 154 mM sodium chloride. Papers 
were transferred to scintillation vials and extracted with 
1 ml of water for one hour, then 10 ml dioxan-based scintillator 
(0.5% (w/v) 2,5-diphenyloxazole and 10% (w/v) naphthalene 
in dioxan) was added and radioactivity measured in a 
scintillation counter (Beckman LS-100). CPM were converted 
to DPM by means of an external standard (see Appendix 1).
For kinetic analysis of uptake, 100 yl of
appropriate concentrations of non-radioactive substrate
were added at the same time as the radioactive substrate.
Blanks were carried out at several different substrate
concentrations over the range used. The results of these
experiments were analysed by the methods of Cl INLAND (1963)
using his Fortran programmes and an IBM 360/50 computer
as described previously (BEART, JOHNSTON & UHR, 1972).
In this procedure the fit of the data is made to the rate
equation in its hyperbolic form and the kinetic constants
determined (v = VA/(K + A); where v = uptake velocity,
V = maximal velocity of uptake (V ), A = substratemax
concentration and K = Michaelis constant (K^ )).
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Potential uptake inhibitors were preincubated 
with the slices for 15 min before the addition of radioactive 
substrate. Using a PDP-8L computer the mean blank was 
subtracted from the four individual determinations for each 
drug or amino acid analogue and a mean - S.E.M. calculated. 
These were compared with the mean control value (no added 
inhibitor) to yield a percentage inhibition of uptake.
Uptake buffer. The Krebs Ringer phosphate buffer solution 
used for uptake consisted of 118.5 mM NaCl, 4.75 mM KCl,
1.77 mM CaCl^/ 1.18 mM MgSO^ and 5.8 mM D-glucose in 15.4 
mM sodium phosphate buffer, pH 7.4. Buffer, kept cold on 
ice, was oxygenated for at least 20 min before being dispensed 
into incubation bottles. For analysis of the dependence of 
uptake of glycine and GABA on external sodium ion 
concentration, the sodium phosphate buffer was replaced 
with tris-HCl buffer, and varying proportions of the sodium 
chloride were replaced by choline chloride.
Bicuculline and strychnine injections. These alkaloids were 
injected intraperitoneally into young rats as 0.5 - 5 mM 
solutions of their hydrochlorides. Control animals received 
0c9% (w/v) saline.,
Metabolism. Under the conditions used, with GABA uptake 
measured after 10 min at 25°C and glycine uptake after 
10 min at 37°C, essentially all accumulated radioactivity 
in the slices remained as unchanged GABA or glycine 
(JOHNSTON & IVERSEN, 1971; IVERSEN & JOHNSTON, 1971).
3Chemicals. [2,3- H] GABA, specific activity 2 Ci/mmol,
3and [2- H] glycine, 10.2 Ci/nimol, were purchased from New 
England Nuclear, Boston. The following compounds were 
gifts: Amiloride (A.W. Cuthbert, Cambridge), N-methyl-GABA
and N,N-dimethyl-GABA (D. Butler, Canberra). The following 
compounds were prepared by published procedures (see BEART
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& JOHNSTON, 1973; HEART, JOHNSTON & UHR, 1972): trans-4-
aminocrotonic acid, 4-amino-tetrolic acid, 4-aminovaleric 
acid and 2-hydroxy-CABA. Hydrazinoacetic acid was prepared 
by the procedure of CARMI, POLLAK & YELLIN (1960). Other 
drugs and amino acids were purchased from commercial suppliers.
3. RESULTS
Kinetics of GABA uptake into slices of cerebral cortex. Both
apparent kinetic parameters for GABA uptake into slices of
cerebral cortex changed during development (Table 4.1). There
was a 20-fold increase in the maximal velocity of uptake
(V ) and a four-fold increase in K from 1-day-old to adult max m 1
rats.
Kinetics of glycine uptake into slices of spinal cord. The
changes in the apparent kinetic parameters for the uptake of
glycine into spinal cord slices (Table 4.2) were less marked
than those for GABA, uptake. There was a 5-fold increase in
V from 1-day-old to adult rats. For the K there was a max m
significant increase from 1-day to 10-day-old animals, but no 
significant change from 10-day to adult animals.
Sodium dependence of glycine and GABA uptake. The changes 
during development in dependence of uptake on the external 
sodium ion concentration were more marked with GABA (Fig. 4.1) 
than with glycine (Fig. 4.2). At only one measured sodium- 
ion concentration (46 mM) did the uptake of glycine differ 
significantly between the 1-day-old and adult rat, whereas the 
uptake of GABA differed at three sodium ion concentrations 
(23, 46 and 72 mM). At all ages studied the uptake of both 
glycine and GABA showed an absolute dependence on added sodium 
ions in the incubation medium, in that measured uptake in 
the absence of external sodium did not differ significantly 
from zero time blank values.
Inhibition of GABA uptake. Of the structural analogues of 
GABA that inhibit GABA uptake (Table 4.3) , several were more 
potent inhibitors of uptake in the tissue from young animals 
than from the adults; N,N-dimethy1-GABA, N-methy1-GABA 
4-amino-valeric acid (4-methyl-GABA) and glycine. The reverse 
was true for a number of drugs (Table 4.3)
Table 4.1. Apparent kinetic parameters for high 
affinity GABA uptake into slices of cerebral 
cortex from rats of different ages
Postnatal
Age
Krn
(m m)
Vmax
(pmol/min/g)
1 day 5 - 1 0.005 - 0.0002
10 days 5 - 1 0.020 - 0.001
Adult* 2 4 — 1 0.129 - 0.006
Initial velocities of GABA uptake were measured at 25°C 
with 8 substrate concentrations (10-167 pM). Slices were 
preincubated for 15 min in the medium before the addition 
of radioactive substrate, and uptake measured after a 
further 10 min incubation. The values are weighted means 
* S.E.M. of 2 experiments, each of which involved quadruplicate 
determinations of uptake at the various substrate concentrations. 
The results of the individual experiments were analysed by 
the method of CLELAND (1963) to yield mean values - S.E.M. of 
the apparent kinetic parameters.
*Values for adults from IVERSEN AND JOHNSTON (1971).Similar values have been obtained in this laboratory 
under experimental conditions which were the same as used 
in the IVERSEN & JOHNSTON (1971) study.
Table 4.2. Apparent kinetic parameters for high 
affinity glycine uptake into slices of spinal cord 
from rats of different ages
Postnatal K V
Age m max(MM) (pmol/min/g)
1 day 1 5 - 2 0.037 - 0.003
10 days 50 - 4 0.142 - 0.008
Adult* 36 - 9 0.21 - 0.05
Initial velocities of glycine uptake were measured at 37°C 
with 5-6 substrate concentrations (5-50 PM). Details as 
for Table 4.1.
*Values for adults from JOHNSTON & IVERSEN (1971).
Fig A  • 1» Analysis of the dependence on external sodium ion con­
centration of [3h] GABA (0.0125 pM) uptake into slices of 
cerebral cortex from 5-hour-old (closed circles), 10-day-old 
(closed triangles) and adult rats (open circles). Uptake 
was measured in medium in which the normal sodium phospha-e 
buffer was replaced by Tris-HCl buffer and in which varying 
proportions of the sodium chloride were replaced by choline 
chloride. The points are means - S.E.M. of four experimental 
values, and uptake is expressed as a percentage of the uptake 
observed at the 'normal' sodium ion concentration.
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Fig.4.2. Analysis of the dependence on external sodium ion con­
centration of pH]glycine (0.57 pM) uptake into slices of 
spinal cord from 1-day-old (closed circles), 10-day-old 
(closed triangles) and adult rats (open circles). Details 
as for Fig. 4.1.
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Table 4.3. Inhibition of high affinity GABA uptake 
into cerebral cortex slices from rats of different ages
% Inhibition of control uptake 
Inhibitor at postnatal age:
1 day 10 days adult
(a) amino acids (0.5 mM) 
trans-4-aminocrotonic acid 
4-aminovaleric acid 
2-hydroxy-GABA
N-methy1-GABA
N,N-dimethyl-GABA
4-aminotetrolic acid
L-2,4-diaminobutyric acid
glycine
(b) drugs (0.1 mM) 
p-chloromercuriphenylsulphonate 
chloropromazine
j uglone
protoveratrine A 
protoveratrine B 
dipyridamole 
ouabain
strophanthidin
amiloride
atractyloside
110 - l 97 - 1 96 - 1
103 + 3 91 +• 1 82 + 1
103 + 1 88 + 1 90 + 1
89 + 4 73 + 1 54 + 1
68 + 2 54 + 2 29 + 2
63 1 57 + 1 55 + 7
53 + 6 50 + 1 47 + 1
27 + 3 11 + 5 n. s.
_ + +95 - 1 93 - 1 92 - 2
+ +94 - 1 n.t. 89 - 1
+ +87 - 1 n.t. 93 - 5
40 - 1 35 - 11 +77 - 4
+ + +35 - 1 38 - 7 70 - 9
+ + +35 - 9 19 - 3 19 - 1
+ + +37 - 8 62 - 1 67 - 1
+ +30 - 5 55 - 1 44 - 2
n.s. 26 - 6 +28 - 5
n.s. n.s. n.s.
The tissue slices were pre-incubated with the inhibitors at 
the concentrations shown for 15 min at 25°C, [^H]GABA 
(0.0125 pM) added and uptake measured after 10 min. Values 
are means ± S.E.M. of results from one or more quadruplicate 
experiments.
n.t. = not tested 
n.s. = not significant
28
ouabain/ protoveratrine A and B were more potent inhibitors 
of GABA uptake in adult tissue than in tissue from 1-day-old 
animals.
Inhibition of glycine uptake. L-a-alanine, D-a-alanine,
3-alanine and GABA inhibited glycine uptake to a greater 
extent in tissue from young animals than in that from adults, 
while the reverse was true for ouabain and the related 
aglycone, strophanthidin (Table 4.4).
Convulsant effects of bicuculline and strychnine. The 
alkaloids bicuculline and strychnine were significantly more 
potent convulsants of 1 - 10-day-old rats than of adult 
rats (Table 4.5). These results are similar to those of 
more extensive studies reported by PYLKKO & WOODBURY (1961) 
and VERNADAKIS & WOODBURY (1969) on the susceptibility to 
strychnine of rats ranging from 1 to 36 days old. In the 
1- and 2-day-old rats, generalized convulsions could not be 
elicited; at these ages the alkaloids produced body tremors, 
often accompanied by tail extension and sideways twisting 
of the body or hind limbs (see also PYLKKO & WOODBURY, 1961). 
At 10 days of age the alkaloids produced seizures comparable 
in type with those observed in adult animals. No gross 
differences were observed in the nature of the convulsions 
induced in the immature animals by strychnine or by 
bicuculline.
4. DISCUSSION
Using slices of adult rat CNS, the high affinity 
uptake of glycine is observed only in tissue prepared from 
the spinal cord and pons-medulla, regions where glycine is 
likely to be a transmitter, whereas the low affinity uptake 
is found in slices prepared from all areas of the CNS 
(JOHNSTON Sc IVERSEN, 1971; NEAL, 1971) . A high affinity
Table 4.4. Inhibition of high affinity glycine uptake 
into spinal cord slices from rats of different ages
^Inhibition of control uptake 
Inhibitor at postnatal age:
1 day 10 days adult
(a) amino acids (1 mM)
hydrazinoacetic acid 79 - 5 71 + 1 93 - 1
L-a-alanine 67 ± 1 43 + 1 8 ± 3
D-a-alanine 57 6 34 + 3 27 - 7
3-alanine 40 ± 2 20 + 4 17 - 9
taurine 40 - 8 20 + 2 30 - 4
GABA 22 - 3 12 + 3 n.s.
2-amino-isobutyric acid 11 ± 3 9 + 1 13 i 6
allylglycine n. s. n.s5 . 22 - 5
L-serine n.s. n.s3. n.s.
(b) drugs (0.1 mM)
juglone 103 - 1 96 + 1 100 - 1
p-chloromercuriphenylsulphonate 99 - 2 86 + 1 100 - 3
chlorpromazine 98 - 2 89 + 1 99 - 2
protoveratrine A n . t . 81 + 1 94 - 1
ouabain 77 - 4 79 + 1 97 - 1
strophanthidin 26 - 12 25 + 11 79 - 2
dipyridamole 58 - 3 53 + 4 56 - 2
pyridoxamine 20 - 6 21 + 5 n.s.
amiloride 20 - 3 13 + 4 n.s.
atractyloside n.t. 21 + 9 a i 1
The tissue slices were pre-incubated with the inhibitors at 
the concentrations shown for 15 min at 37°C, [^H]glycine
(0.57 juM) added and uptake measured after 10 min. Values 
are means ^ S.E.M. of results from one or more quadruplicate 
experiments.
n . t. 
n . s.
not tested 
not significant
Table 4.5. Convulsant doses of bicuculline and strychnine
in rats of different ages
Postnatal
Age
CD5q (ymo1/kg i.p.) 
Bicuculline Strychnine
1 day 1.4 + C.7 1.8 + 0.4
2 days 2.6 ± 0.2 2.2 ± 0.2
10 days 1.2 + 0.4 2.8 T 0.05
Adult 12.1 ± 0.6§ 6§§
For each age group, 3-4 different doses of the alkaloids were 
injected intraperitoneally to each of 4 animals, and 
convulsions scored if occurring within 5 min. The percentage 
convulsing at each dose was plotted on a probability scale 
against the log of the dose to obtain an estimate of the
§ JOHNSTON 6* MITCHELL (1971). 
§§ PYLKKO & WOODBURY (1961).
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uptake for glycine, strictly dependent on sodium, has been 
demonstrated in synaptosomal preparations of spinal cord 
(BENNETT, LOGAN & SNYDER, 1972) but not of cerebral cortex 
(LOGAN & SNYDER, 1972). These results suggest that within 
the CNS, the sodium-dependent high affinity transport of 
glycine is associated with its transmitter function.
A high affinity uptake for GABA is present in 
slices of all regions of the CNS (IVERSEN & JOHNSTON, 1971): 
on the basis of maximal rates of uptake measured in vitro, 
results are consistent with the view that GABA is a major 
inhibitory transmitter in supraspinal regions, but of less 
importance in spinal inhibitory mechanisms. For GABA uptake 
into cortex and glycine uptake into cord, experiments 
(JOHNSTON & IVERSEN, 1971; IVERSEN & JOHNSTON, 1971) have 
shown that more than two-thirds of the uptake sites in slices 
of intact tissue are still present in homogenates and that 
radioactivity accumulated by homogenates is associated with 
osmotically sensitive particles with sedimentation 
characteristics of synaptosomes. Autoradiographic evidence 
for a predominantly synaptic-terminal localization of 
accumulated glycine and GABA in tissue slices has been 
discussed (Section IV.1). A recently described low affinity 
transport for GABA in CNS tissue slices and homogenates 
(LEVI & RAITERI, 1973; BOND, 1973) has yet to be studied 
extensively.
The high affinity uptake systems for GABA and 
glycine found in CNS tissue slices from adult rats are 
present in tissue from 1- and 10-day-old animals. The 
high affinity uptake of GABA has been investigated previously 
in slices of immature rat brain by LEVI & RAITERI (1973), 
who also demonstrated the existence of a low affinity 
system. LEVI & RAITERI (1973) found a slightly higher Km
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for GABA uptake into newborn brain slices (43 ;uM) than into 
adult brain slices (31 uM), whereas the present investigation 
suggests that the for high affinity GABA uptake increases 
during post-natal development. For both GABA and glycine 
the maximal velocity of uptake increases with development 
suggesting possibly an increased density of transport sites.
For glycine uptake into spinal cord slices, the developmental 
change in was less marked than that for GABA uptake in the 
cortex. From 10-day-old to adult rats, there was no signifi­
cant difference in the K . Relative constancy of K and 
increases in the maximal velocity of uptake during development 
have been reported for a number of substrates including 
noradrenaline in rat brain (COYLE & AXELROD, 1971) and 
-aminoisobutyric acid, L-leucine, D-glutamate and L-lysine 
in chick brain (LEVI, 1972).
Recent work on developmental changes for glycine 
uptake into rat cerebral synaptosomal fractions (PETERSON 
& RAGHUPATHY, 1973) suggests that accumulation proceeds by 
two independent system, one totally dependent on external 
sodium, the other independent of sodium. The sodium-dependent 
system was more active in fractions from nev/born and adult rats 
than in fractions from 12 -17-day-old animals; in these, 
the sodium-independent system v/as more active and its contri­
bution to total uptake declined with development. This uptake 
demonstrated high affinity kinetics and v/as characterized by 
a decline in V and increase in K with development from 
12 - 17-day-old to adult animals. The function and subcellular 
site(s) of this sodium-independent accumulation is at present 
unknov/n. BENNETT, LOGAN & SNYDER (197 3) have also reported 
Na-dependent and independent glycine uptake into rat cerebral 
synaptosomes, although they find a. somewhat different 
developmental pattern.
A substrate for a particular transport system 
v/ill effectively inhibit the observed uptake of another
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substrate by this transport system when present in sufficient 
molar excess to overcome differences in affinity of the two 
substrates for the transport system: thus, putative substrates
can be screened rapidly and an assessment made of the possible 
substrate specificity. In adult rats the high affinity 
uptake systems for glycine and GABA are essentially independent. 
In the 1- and 10-day-old rats, however, there is a small 
but significant inhibition by GABA of the uptake of glycine 
and vice versa, suggesting that in these animars the transport 
systems may be less specific than in the adults. There are 
some other changes with development in the susceptibility 
of the two systems to inhibition by amino acid analogues 
which also indicate increased specificity of the transport 
carrier with development. Other authors have noted changes 
in the apparent substrate specificity with development of 
other amino acid transport systems (PICCOLI, GRYBAUM & LAJTHA, 
1971; LEVI, 1972).
Inhibition of GABA and glycine uptake by drugs 
interfering with sodium ion channels is generally more 
apparent in adult tissue than in that from immature animals.
The veratrine alkaloids, protoveratrine A and B, apparently 
interfere with sodium ion movements by stabilizing the 
sodium-ion-selective channels once they have been formed 
(BAKER, 1968), but act at different sites to ouabain and 
do not affect the sodium/potassium dependent ATPase (YOSHIDA, 
KANIIKE & NAMBA, 1963). It has been proposed that 
protoveratrine may exert its effect by blocking sodium- 
dependent binding of GABA to the membrane, a process that 
may occur before membrane transfer (GOTTESFELD & ELLIOT, 1971). 
Strophanthin, an aglycone structurally related to ouabain 
blocks active sodium transport in a variety of preparations 
(HOROWICZ & GERBER, 1965) . Amiloride, a potent inhibitor
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of sodium transport in toad bladder (CUTHBERT & WONG, 1972) 
was only a weak inhibitor of GABA and glycine uptake in tissue 
from young and adult rats.
Slight differences in the dependence on the 
external sodium ion concentrations are observed for GABA 
and glycine uptake into tissue prepared from animals of 
different post-natal ages. In common with other high 
affinity amino acid transport systems in adults (BENNETT,
LOGAN & SNYDER, 1972), the systems for GABA and glycine 
showed an absolute dependence of sodium ions at all ages 
examined. Plotting the rate of uptake of glycine into 
spinal cord slices of young and adult tissue versus sodium 
ion concentration (Fig. 4.2) revealed sigmoidal curves 
reminiscent of allosteric interactions found in certain 
enzyme systems. Similar results have been reported for 
glycine uptake into spinal cord homogenates (BENNETT, LOGAN 
& SNYDER, 1973) and suggest possible allosteric interactions 
between sodium ions and the glycine transport system. A 
sigmoidal curve has been observed for the sodium-dependence 
of GABA uptake by cerebral cortical synaptosome? (MARTIN 
& SMITH, 1972). The sodium requirement of L-glutamate 
uptake in homogenates and slices of cortex, however, appears 
to be less complex (BENNETT, LOGAN & SNYDER, 1973; BALCAR 
& JOHNSTON, 1972a).
In the cat CNS, bicuculline and strychnine have 
been shown to be relatively specific antagonists of the 
post-synaptic actions of 'GABA-like' and 'glycine-like' 
amino acids respectively (CURTIS, HÖSLI, JOHNSTON & JOHNSTON, 
1968; CURTIS, DUGGAN, FELIX & JOHNSTON, 1971). In the 
rat cord this is also the case. In the rat cortex, bicuculline 
antagonized the actions of the depressant amino acids while 
strychnine had no specific antagonistic effect, possibly
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reflecting the lower proportion of neurons relatively 
sensitive to glycine in the cortex than in the cord (BISCOE, 
DUGGAN & LODGE, 1972) . The convulsions produced in 1-, 2- 
and 10-day-old rats by these antagonists suggests that at 
these ages the depressant amino acids, glycine and GABA 
are being used as transmitters. However, maturational 
changes in the blood-brain barrier to these alkaloids (PYLKKO 
& WOODBURY, 1961; VERNADAKIS & WOODBURY, 1969) and the 
hepatic drug-metabolizing system (DAVIS & YEH, 1969) could 
influence the amount of these convulsants reaching post- 
synaptic receptor sites. Thus it is not possible to deduce 
from the present CD^0 measurements the degree to which 
glycine and GABA are being used as inhibitory transmitters.
Although recent work has shown that for GABA and 
L-glutamate at least, a high affinity uptake exists in 
peripheral nervous system tissue where on current evidence 
they are unlikely to have a transmitter function, most 
experimental findings considered above suggest that within 
the central nervous system the association of sodium dependent 
high affinity uptake systems and the probable transmitter 
function of certain amino acids is good. Thus it is tempting 
to speculate that the existence of sodium dependent, high 
affinity uptake systems for GABA and glycine in 1-day-old 
rats is indicative of them functioning as transmitters at 
this stage. However, it is possible that the development 
of uptake systems precedes transmitter function; developing 
synapses may accumulate amino acids before they are 
morphologically (ADINOLFI, 1971) or physiologically mature, 
or newly-differentiated glial cells insulating developing 
synapses may possess the ability to transport amino acids 
from the extra-cellular environment. In this regard it is 
interesting to note that membrane-receptor sensitivity 
appears to precede development of functional synapses, since 
micro-electrophoretically applied GABA and noradrenaline 
can inhibit the spontaneous discharges of immature Purkinje 
cells in 1-day rat cerebellum (WOODWARD, HOFFER & LAPHAM, 
1969). Alternatively, transmitter function and high affinity
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uptake into terminals may develop simultaneously, since there 
is some evidence to suggest that mechanisms responsible for 
sodium-dependent, high affinity transport of putative amino 
acid transmitters may be involved in their release from 
presynaptic terminals (e.g. LEVI & RAITERI, 1974) . Obviously 
further studies are required before definite conclusions 
can be drawn as to the association of the presence of high 
affinity uptake systems for amino acids in immature animals 
and their function as transmitters. Additional experiments 
could include -
1. A comparison of glycine uptake in the spinal cord and 
cerebral cortex of immature animals, in view of the 
finding (JOHNSTON & IVERSEN, 1971) that the high affinity 
uptake is only present in those regions where glycine
is likely to be a transmitter.
2. An extensive study of GABA uptake in the cerebellum
at a large number of stages during growth and maturation.
The cerebellum may be the best brain region in which to 
attempt to relate developmental changes in neurochemical 
correlates of synaptically-active amino acids to changes 
in the number of synaptic junctions, since the developing 
cerebellum has been studied extensively with respect 
to cellular and morphological changes (e.g. ALTMAN, 1966, 
1969) and estimates have been made of developing synaptic 
junction numbers (WOODWARD, KOFFER, SIGGINS & BLOOM, 1971) .
3. Electron-microscope autoradiographic studies of uptake 
of putative amino acids in slices and homogenates of 
immature tissue, under conditions of labelling in which 
high affinity uptake predominates. Such studies of [^HJGABA 
uptake in slices of rat cerebellum may be particularly 
worthwhile, in view of the well known inhibitions 
mediated by GABA in the adult cerebellum (CURTIS & JOHNSTON, 
1974) .
As discussed above, the problem with approaches (2) and (3) is 
that the terminals appearing in morphological studies of
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immatue tissue may not be synaptically active. A combined 
morphological and electorphysiological approach could help 
to determine at what stage of ultrastructural development 
a synapse becomes functional, although the problems of 
electrophysiological recording in immature brain (WOODWARD, 
HOFFER & LAPHAM, 1969) may render such an approach impractical.
In addition to the existence of sodium dependent, 
high affinity uptake systems for glycine and GABA, it has 
been shown that compounds which antagonise the postsynaptic 
actions of these amino acids cause convulsions in 1 and 2- 
day-old rats. In the following chapter the ability of immature 
rat CNS tissue to release these amino acids in vitro under 
conditions of stimulation which may approximate a model of 
in vivo synaptic release is examined.
V. POSTNATAL CHANGES IN THE POTASSIUM-STIMULATED, 
CALCIUM-DEPENDENT RELEASE OF RADIOACTIVE GABA AND GLYCINE
FROM SLICES OF RAT CENTRAL NERVOUS TISSUE
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1. INTRODUCTION
An important criterion for the establishment 
of a neurotransmitter role for a substance is that it should 
be released from nerve terminals by presynaptic impulses.
A rigorous experimental proof of release is very difficult 
for central synaptic transmitters and results of most 
investigations on endogenous amino acid efflux from the 
CNS have provided, at most, indirect evidence of synaptic 
release of putative amino acid transmitters by impulses 
in particular pathways.
The release of GABA from the mammalian cortex 
has been studied in vivo, in response to stimulating various 
pathways (JASPER & KOYAMA, 1969; OBATA & TAKEDA, 1969;
IVERSEN, MITCHELL & SRINIVASAN, 1971). There is now 
substantial evidence that GABA is released by neural activity, 
especially in the cerebral cortex and Deiter's nucleus.
It has proved difficult to demonstrate changes in the 
release of glycine from the spinal cord after nerve stimulation, 
although JORDAN & WEBSTER (1971) did observe increased efflux 
of radioactive glycine from cat spinal cord perfused in vivo 
as a result of stimulating various nerves, provided 
p-hydroxymercuribenzoate was present in the superfusate, 
presumably to block re-uptake (NEAL Sc PICKLES, 1969) .
APRISON (1970) has observed release of radioactive glycine 
from hemisected toad spinal cord as the result of dorsal-root 
stimulation.
The calcium-dependent release of radioactive amino 
acids from preloaded slices and synaptosome preparations 
of adult CNS tissue in response to electrical stimulation 
or high potassium concentration has been studied extensively 
as a model for transmitter release (e.g. MACHIYAMA, BALAZS 
6c RICHTER, 1967; SRINIVASAN, NEAL 6c MITCHELL, 1969; KATZ,
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CHASE Sc KOPIN, 1969; HOPKIN & NEAL, 1971; HAMMERSTAD,
MURRAY 6c CUTLER, 1971; ARNFRED 6c HERTZ, 1971; MULDER 6c 
SNYDER, 1974). This type of experiment serves to 
eliminate some of the difficulties encountered in studying 
amino acid release in vivo, including the problem of 
collection of sufficient amounts of endogenous amino acid 
to quantify, as well as the inability to collect directly 
at the site of release. However the ability to stimulate 
particular neuronal pathways is lost; furthermore, care 
must be exercised in equating release of preloaded exogenous 
amino acid with release of endogenous compound from a 
transmitter pool, because of possible metabolic compartmentation 
(BERL 6c CLARKE, 1969; VAN DEN BERG, 1973).
In this chapter a simple system, made from readily 
available apparatus, has been used to study potassium- 
stimulated release of amino acids from 'mini-slices'
(0.1 x 0.1 x 1-2 mm) of CNS tissue. 'Mini-slices' have 
commonly been used for studying those high affinity uptake 
systems which appear to be associated with transmitter 
pools of amino acids, but previous release studies have 
usually been carried out with relatively large slices (e.g.
0.5 x 1 x 1 mm cerebral slices; MULDER 6c SNYDER, 1974;
1 mm transverse discs of spinal cord; HOPKIN 6c NEAL, 1971) .
The apparent kinetics of amino acid uptake into rat brain 
slices can be influenced by the size of the slices, with 
'low affinity' uptake predominating over 'high affinity' 
uptake in thicker slices (LEVI 6c RAITERI, 197 3) . In the 
case of glycine, 'low affinity' uptake is much less specific 
than the 'high affinity' uptake and may serve a general 
metabolic function (JOHNSTON 6c IVERSEN, 1971). 'Mini-slices' 
were used in order to minimise uptake of radioactivity by 
'low affinity' systems.
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This apparatus was used to examine whether a 
potassium-stimulated, calcium-dependent release could be 
observed from slices of cerebral cortex and spinal cord 
prepared from rats of 1 day and 10 days postnatal age.
2. METHODS AND MATERIALS
Preparation of tissue slices. Wistar rats of 1 day, 10 days 
or 13 weeks postnatal age were killed by decapitation and 
the brains or spinal cords rapidly removed. The cerebral 
hemispheres were separated from the brainstem and midbrain 
(diencephalon and mesencephalon) and, in the case of adult 
rats, dissected free of underlying white matter. The 
spinal cords were freed from spinal roots and the dura removed. 
The tissue was chopped into 'mini-slices' (approximately 
1.0 x 0.1 x 0.1 mm) using a Mcllwain tissue chopper and 
suspended in cold buffer (1 ml per 100mg tissue). Aliquots 
of 500 pi were distributed to incubation bottles containing 
5 ml of cold oxygenated buffer.
Incubation of slices. Slices were preincubated with shaking 
at 37°C for 10 min before the addition of amino-oxyacetic 
acid (2 x 10  ^M final concentration) and [u-^c] GABA,
(0.5 pCi) , [2-^h] glycine or [i-"*" c] 2-aminoisobutyric acid
(1.0 pCi). Amino-oxyacetic acid was added to inhibit the 
catabolism of GABA (COLLINS, 1973). The slices were 
incubated for a further 20 min, then collected by vacuum 
filtration on glass fibre filter discs (Whatman GF/A, 2.5 cm 
diameter) and washed with 10 ml of warm (37°C) buffer.
Perfusion of slices. The filter discs were transferred 
rapidly to filter holders (Swinnex 25, Millipore Corp.) 
and perfusion commenced. The apparatus (Fig. 5.1) consisted 
of up to 7 Swinnex filter holders held by spring tool 
clips on a 37°C water bath. A multichannel peristaltic 
pump (Buchler Dekastaltic) was used to pump oxygenated
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Krebs Ringer buffer solution through a heating coil contained 
in the bath and into the adapters at a rate of 0.5 ml/min. 
Fractions (2.8 min) were collected using an automatic 
fraction collector (Isco, model 328), modified to collect 
up to 7 fractions at once directly into scintillation vials 
(fractions were changed as each row of vials moved sideways). 
Slices were perfused with normal buffer for different times 
before switching to high K-buffer for 10 min. Perfusion was 
continued with normal buffer, then the system was pumped 
dry and the filter discs with tissue were removed and 
transferred to scintillation vials containing 1 ml of water.
In initial experiments on GABA release, slices 
were perfused with normal buffer for 40 min before the 
10 min high-potassium stimulation. However, this initial 
perfusion time was reduced to 25 min for adult and 10-day 
cortex slices, and to 30 min for 1-day cortex slices, since 
it was observed that pre-stimulation spontaneous efflux 
reached a constant level within these times. Unlike GABA 
release from cortex, the resting release of glycine from 
spinal cord slices did not attain a constant basal level.
To determine what effect this had on the measured release 
parameter (peak percentage increase over immediate 
pre-stimulation spontaneous efflux) the experiments were 
repeated using longer initial perfusion times. The calculated 
potassium-stimulated release of glycine was not significantly 
different in experiments involving 25 min, 35 min and 40 min 
initial perfusion times. Thus 30 min perfusion was routinely 
used. A 25 min pre-stimulation perfusion was used for 2-amino- 
isobutyric acid.
Perfusion buffer. The 'control' Krebs Ringer buffer solution 
used for uptake and release consisted of 118.5 mM NaCl,
4.75 mM KCl, 1.77 mM CaCl^^l.lö mM MgSO^, and 5.8 mM D-glucose
Fig, 5.1. Apparatus used to perfuse 'mini-slices' of nervous 
tissue. The slices were retained on glass-fibre filter discs 
in Swinnex filter holders. Up to seven such holders were used 
in parallel.
Z  UJ
►" O
i 1 I
38
in 15.4 mM sodium phosphate buffer, pH 7.4, oxygenated 
before incubation of slices and during the course of release 
experiments. Calcium-free buffer was normal buffer with 
CaCl^ omitted. For high K-buffer, KCl was increased from 
4.75 to 44.75 mM. Low sodium buffer had the NaCl replaced 
with choline chloride (118.5 mM) reducing the sodium ion 
concentration to approximately 26 mM.
Chemicals. Chemicals were purchased from the following3sources; amino-oxyacetic acid (Eastman); [2- H]glycine,
1410.2Ci/mmol (New England Nuclear, Boston); [U- cJGABA,
14228 mCi/mmol and [1- c]aminoisobutyric acid, 53.8 mCi/mmol 
(Radiochemical Centre, Amersham); Teric N8 detergent (Imperial 
Chemical Industries, Australia) and 2,5-diphenyloxazole 
(Merck).
Radioactivity in the aqueous samples was determined 
by liquid scintillation counting after the addition of 9 ml 
of scintillator. This scintillator contained 0.5% (w/v) 
of 2,5-diphenyloxazole in a 2:1 mixture of xylene:Teric 
N8 detergent.
Metabolism. The extent of metabolism of radioactive GABA and 
glycine occurring during the course of perfusion experiments 
was examined. For analysis of radioactivity retained in the 
tissue at the end of perfusion, tissue slices on filter discs 
were homogenized in 0.45 N perchloric acid or 0.5 N 
trichloroacetic acid and supernatants collected by 
centrifugation. Perchloric acid extracts were neutralized 
with potassium hydroxide and insoluble potassium perchlorate 
removed by centrifugation, while trichloroacetic acid was 
removed from supernatants by ether extraction. For analysis 
of released radioactivity, efflux fractions were pooled and 
concentrated in vacuo. Acidified samples of tissue 
radioactivity and released radioactivity were applied to
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small columns of Dowex 50W x 4 (200-400 mesh), washed with 
0.01 N hydrochloric acid and water, then eluted with 2 N 
ammonia solution. Aliquots of the wash were counted to 
determine radioactivity in acidic metabolites, while the 
alkaline eluent was evaporated to dryness in vacuo at 37°C, 
resuspended in a small volume of water and analysed by paper 
electrophoresis or thin-layer chromatography on micro­
crystalline cellulose (Avicel). In other experiments, tissue 
radioactivity was analysed directly without prior column 
fractionation. Electrophoresis buffer was 2% pyridine, 1% 
acetic acid, pH 5.2. The solvent for chromatography of glycine 
was butanol:acetone:diethylamine:water (20:20:3:10) which 
clearly separated glycine and serine, and for GABA, butanol: 
acetic acid:water (4:1:1).
3. RESULTS
Release of radioactive amino acids from slices of adult 
rat cerebral cortex
GABA. As previously observed using larger slices (SRINIVASAN, 
NEAL & MITCHELL, 1969; MULDER & SNYDER, 1974) of adult rat 
cerebral cortex, increasing the potassium ion concentration 
in the perfusing buffer led to a markedly enhanced release 
of radioactive GABA, and this K-stimulated release was almost 
completely abolished if the perfusing buffer contained no 
added calcium ions (Fig.5.2). The results of individual 
experiments can be expressed in terms of the peak percentage 
increase over the immediate pre-stimulation spontaneous 
release of radioactivity, as described by MULDER & SNYDER 
(1974); this data is presented in Table 5.1.
Lowering the sodium ion content of the perfusing 
medium from 146 mM to 26 mM had the effect of slightly 
increasing the spontaneous release of radioactivity and 
greatly increasing the K-stimulated release (Fig.5.2, Table 5.1).
14 14Fig. 5.2. Release of [u- c]GABA and [1- c]2-aminoisobutyric 
acid from slices of adult rat cerebral cortex. The slices 
(50 mg) were preloaded by incubation in buffer at 37 C for 
20 min with either 0.5 pCi of GABA or 1.0 pCi of 2-aminoisobutyric 
acid, collected by filtration on a glass-fibre filter disc, 
washed with warm buffer, transferred to Swinnex filter holder 
and perfused at 37°C with Krebs Ringer phosphate buffer. Each 
point represents the mean * S.E.M. of 3-4 experiments, of the 
radioactivity in fractions of the perfusate collected over 2.8 
min periods. The 'control' curve represents perfusion with buffer 
containing 1.77 mM CaC^/ while the curve labelled 'no added 
calcium' represents experiments in which the calcium chloride 
was omitted from the perfusion buffer. The hatched bar represents 
perfusion with buffer containing 44.75 mM KCl for the 10 min 
period indicated (normal KCl is 4.75 mM).
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Table 5.1. Potassium-stimulated release of radioactive 
amino acids from adult rat CNS tissue slices
K-Stimulated release
+ Calcium - Calcium
(a) Cerebral cortex slices
GABA 505 - 54 (6) 63 + 11 (4)
(Low Na) * 763 - 69 (5) -
(Low Na)** 1006 -141 (5) -
2-Aminoisobutyric acid 8 i i (5) -
Glycine 34 +- 4 (4) 21 + 3 (4)
(b) Spinal cord slices
GABA 368 - 75 (3) 61 + 15 (5)
2-Aminoisobutyric acid -1 - 2 (5) -
Glycine 63 ± 4 (5) 13 + 3 (4)
K-Stimulated release is expressed as the peak percentage 
increase in release over immediate pre-stimulation spontaneous 
release. Values are means - S.E.M. for the number of 
experiments shown in brackets.
* Expressed as increase over low Na resting release
** Expressed as increase over normal Na resting release
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2-Aminoisobutyric acid. Increasing the potassium ion
concentration in the perfusing buffer did not lead to any-
marked increase in the release of radioactivity from slices
r 14 ,preloaded with LI- CJ2-aminoisobutyric acid (Fig. 5.2,
Table 5.1).
Glycine. There was a significant increase in the rate of 
release of radioactivity from adult cerebral cortex slices 
in response to perfusion with high K-buffer, and this 
K-stimulated release was in part dependent on calcium ions 
in the perfusing buffer (Table 5.1).
Release of radioactive amino acids from slices of adult 
rat spinal cord
GABA. There was an appreciable calcium-dependent, 
K-stimulated release of radioactive GABA from slices of adult 
rat spinal cord (Table 5.1). This stimulated release was 
not significantly different from that observed from slices 
of adult rat cerebral cortex.
2-Aminoisobutyric acid. Radioactive 2-aminoisobutyric acid 
was not released by high K-buffer (Table 5.1).
Glvcine. The calcium-dependent, K-stimulated release of 
glycine from slices of adult spinal cord was approximately 
twice that observed from slices of adult cerebral cortex 
(Table 5.1).
Postnatal changes in the stimulated release of radioactive 
GABA from slices of cerebral cortex. Calcium-dependent, 
K-stimulated release of radioactive GABA was apparent with 
slices of cerebral cortex from 1-day and 10-day-old animals 
(Fig.5.3, Table 5.2). With increasing age there appeared 
to be an increase in the amount of radioactive release on 
K-stimulation.
14Fig. 5.3. Release of [U- c] GABA from slices of cerebral 
cortex from animals of 1 day and 10 days postnatal age. Other 
details as for Fig. 5.2.
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Table 5.2. Postnatal changes in potassium-stimulated release 
of radioactive GABA from slices of cerebral cortex
K-Stimulated release
Postnatal age of animals + Calcium - Calcium
1 Day 104 + 17 (7) 27 + 3 (3)
10 Days 249 + 29 (5) 76 + 9 (6)
Adult (13-week) 505 + 54 (6) 63 + 11 (4)
K-Stimulated release is expressed as the peak percentage 
increase in release over immediate pre -stimulation spontaneous 
release. Initial perfusion time for adult and 10-day cortex 
slices was 25 min and for 1-day slices, 30 min. Values 
given are means * S.E.M. of the number of experiments shown 
in brackets.
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Postnatal changes in the stimulated release of radioactive 
glycine from slices of spinal cord. Little difference 
could be discerned in the calcium-dependent, K-stimulated 
release of radioactive glycine from cord slices prepared 
from 1-day, 10-day and 13-week-old animals (Fig.5.4, Table 
5.3) .
Radioactivity retained in the tissue after perfusion. The 
percentage of the total accumulated radioactivity retained 
in the tissue slices at the conclusion of each set of 
perfusion experiments is given in Table 5.4. In all 
experiments using radioactive GABA, more than 80% of the 
radioactivity remained in the tissue slices: this retained
radioactivity did not represent 'non-releasable' GABA since 
a second high K-stimulus (10 min) could release as much 
radioactivity from slices of adult cerebral cortex as did 
the first stimulus (Fig.5.5). It is apparent that the 
changes observed in K-stimulated GABA release with development 
are not due to differences in the amount of accumulated 
radioactive GABA present in the tissue at the onset of the 
K-stimulus. In general the <K-amino acids, 2-arrinoisobutyric 
acid and glycine, were retained less efficiently than was 
GABA.
Metabolism
GABA. The extent of metabolism of GABA released from 
1-day-old rat cortex slices, before, during and after 
high-potassium stimulation was examined. Radioactivity 
released from slices of 1-day rat cortex during a 60 min 
perfusion was collected in three fractions which were 
released over 15 min periods before, during and after a 
10 min high-potassium stimulus. Radioactivity was analysed
3Fig. 5.4. Release of [2- H] glycine from slices of spinal 
cord from animals of 1 day and 10 days postnatal age. Other 
details as for Fig. 5.2 except 1 pCi of radioactivity was 
used.
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Table 5.3. Postnatal changes in potassium-stimulated 
release of radioactive glycine from 
slices of spinal cord
K-Stimulated release
Postnatal age of animals + Calcium - Calcium
1 Day 
10 Days
Adult (13-weeks)
5 2 - 7  (4) 
72 i 5 (5) 
6 3 - 4  (5)
1 9 - 6  (3) 
1 8 - 3  (4) 
1 3 - 3  (4)
K-Stimulated release is expressed as the peak percentage 
increase in release over immediate pre-stimulation spontaneous 
release. Values given are means - S.E.M. of the number of 
experiments shown in brackets. Initial perfusion time with 
normal buffer before switching to high K was 30 min.
Table 5.4. Percentage of accumulated radioactivity 
retained in tissue at end of perfusion
Total
Rat age Perfusion 
Time (min)
+ Ca
Cortex
- Ca
Spinal cord
+ Ca - Ca
(a) GABA 
1 Day 
10 Days 
13 Weeks
55
50
50
8 5 - 2
9 0 - 4  
+
(5)
(5)
+8 7 - 1  (3)
+9 5 - 1  (6)
+94 - 0.5(4) 9 6 - 1  (2) 8 1 - 1  (3) 8 7 - 1  (5)
(b) 2-Aminoisobutyric acid
13 Weeks 50 
(c) Glycine
4 7 - 2 (5) +
1 Day 
10 Days
I13 Weeks
65
65
65
3 8 - 2  (5)
6 8 - 1  (4) 6 8 - 4  (4)
67 - 3 (5) 80 - 1 (5)
56 i 2 +(4) 5 6 - 2  (4) 5 3 - 3  (5) 5 6 - 2  (4)
The amount of accumulated radioactivity retained in tissue 
slices at the end of each set of experiments is given, along 
with total perfusion times. Values given are means - S.E.M. 
of the number of experiments shown in brackets.
14Fig. 5.5. Release of [U- c]GABA from slices of adult rat 
cortex in response to two high-potassium stimuli, each separated 
by 20 min perfusion with normal buffer. Each point represents 
the mean - S.E.M. of 3 separate perfusion experiments. Other 
details as for Fig. 5.2.
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by Dowex 50W fractionation and thin-layer chromatography. 
In the released fractions, 75%, 71% and 71% of the 
radioactivity remained as unchanged GABA respectively, 
while 76% of the acid-soluble radioactivity remaining 
in the slices at the end of the perfusion was unchanged 
GABA (values are the means of two experiments).
In one experiment, with adult rat cortex slices, 
the peak of radioactivity released during high-potassium 
stimulation was analysed. 74% of the released radio­
activity was found as unchanged GABA, while GABA 
accounted for 76% of the acid-soluble radioactivity 
retained in the slices at the end of the 75 min 
perfusion.
Glycine. Radioactivity released from pre-labelled 
slices of 1-day-old rat spinal cord was pooled in three 
fractions collected over 15 min periods before, during 
and after 10 min high-potassium stimulus. Of the 
radioactivity released before, during and after the 
stimulus, 78%, 74% and 63% remained as unchanged glycine, 
while 89% of the acid-soluble radioactivity retained 
by the tissue after a 60 min perfusion was unchanged 
glycine (values are the means of two experiments).
80% of the acid-soluble radioactivity retained 
by adult rat cortex slices after 65 min perfusion ran 
as a single spot on thin-layer chromatography in a 
position equivalent to glycine.
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4. DISCUSSION
A potassium-stimulated release of radioactive 
GABA and glycine has been demonstrated from slices of 
cerebral cortex and spinal cord respectively, from rats 
of 1 day, 10 days and 13 weeks postnatal age. This stimulated 
release was largely calcium-dependent, as is common to 
neurosecretory processes (RUBIN, 1970; SIMPSON, 1968).
The initiating factor in release of transmitters 
from terminals appears to be depolarization of the terminal 
rather than ionic fluxes which produce the depolarization 
(HUBBARD, 1973). The high potassium concentration used in 
these experiments has been shown to depolarize neurones in 
brain slices (HILLMAN & McILWAIN, 1961). A survey of studies 
on release of amino acids suggests that it is easier to 
demonstrate calcium dependence of release mechanisms when 
tissue is stimulated with high K rather than with electrical 
impulses (see e.g. MULDER & SNYDER, 1974). Such an 
observation has been made for neurohumoral release mechanisms 
(RUBIN, personal communication cited by SRINIVASAN, NEAL 
& MITCHELL, 1969), and may be explained by the fact that 
potassium ions appear to have a potentiating action on 
transmitter release in addition to their depolarizing action 
(at least at cholinergic synapses; PARSONS, HOFFMAN &
FEIGEN, 1965; GAGE & QUASTEL, 1965). Such an action 
may result from potassium mobilizing more quanta into the 
readily-releasable store (PARSONS et al., 1965).
A substantial increase in the K-stimulated release 
of radioactive GABA from slices of adult rat cerebral cortex 
was observed when the sodium concentration in the perfusing 
medium was lowered to 26 mM. Similar observations have been 
made for catecholamine release from the adrenal medulla 
(DOUGLAS, 1966), acetylcholine release at the neuromuscular
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junction (GAGE & QUASTEL, 1966), noradrenaline release from 
the spleen (KIRPEKAR & WAKADE, 1968) and the release of 
vasopressin and oxytocin from the neurohypophysis (DOUGLAS 
& POISNER, 1964). A possible explanation for the observed 
increase in GABA release could be that it is the result of 
inhibition of a sodium-dependent re-uptake mechanism 
(BENNETT, LOGAN & SNYDER, 1972: SNYDER, YOUNG, BENNETT &
MULDER* 1973; see also previous chapter, Section IV.3).
The perfusion system used should ensure relatively rapid 
removal of buffer surrounding the tissue slices, although it 
is possible that equilibration of perfusing medium with 
extracellular spaces in the tissue may be slow enough to 
allow some re-uptake. Another possible explanation involves 
a sodium-calcium antagonism such as has been observed at the 
neuromuscular junction (GAGE & QUASTEL, 1966; BIRKS,
BURSTYN & FIRTH, 1968). The inward movement of calcium is 
likely to be a critical step in the process of 'stimulus- 
secretion coupling' (RUBIN, 1970). Calcium has been proposed 
to interact with a receptor on the presynaptic membrane 
which influences transmitter release; sodium may compete 
with calcium by binding to the receptor or may reduce the 
ability of calcium to bind to the receptor. In the squid 
axon, it has been shown that calcium influx is increased 
5-40 times when external sodium is removed (BAKER, BLAUSTEIN, 
HODGKIN & STEINHARDT, 1969). An examination of the effect 
of polyvalent cations on the stimulus-coupled secretion of 
radioactive GABA from rat brain synaptosomes (LEVY, HAYCOCK 
& COTMAN, 1974) suggests that the system is 'strikingly 
similar' to the release of acetylcholine from the neuromuscular 
junction.
For GABA release from cortex slices, there is an 
increase in the measured release parameter with development,
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with significant K-stimulated, calcium-dependent release 
being measured in tissue from 1-day rats. It is possible 
that this increase reflects the development of inhibitory 
synapses in the cerebral cortex. The development of synaptic 
junctions has been observed in the parietal cortex molecular 
layer of rats 12 days to 12 weeks old (AGHAJANIAN & BLOOM,
1967). Few synaptic junctions were evident on postnatal day 
12 or 13; however, deeper cortical layers showed earlier 
development than the outermost layers (EAYRS & GOODHEAD, 1959).
Preliminary observations have been made on synaptic 
development in rat spinal cord (MAY & BISCOE, 1973).
The appearance of synapses has been observed at foetal days 
14-18 (gestation period, 21 days); the calcium-dependent, 
K-stimulated release of glycine from cord slices of 1-day-old 
animals may represent neurotransmitter release from 
inhibitory synapses. The phenomenon of potassium-stimulated, 
calcium-dependent release of amino acids from brain slices 
may be considered only as an approximate model for the 
release of transmitters from presynaptic terminals however, 
since the cellular origin of the released radioactivity is 
uncertain (CURTIS & JOHNSTON, 1974). Although several 
studies have shown a presynaptic location of accumulated 
radioactive GABA and glycine (IVERSEN & BLOOM, 1972;
MATUS AND DENNISON, 1972), it is clear that glial elements 
are also involved (HÖKFELT & LJUNGDAHL, 1972; LJUNGDAHL 
& HÖKFELT, 1973a, b). Some experimental findings pertinent 
to this problem have been discussed in the previous chapter 
(Section IV.1). Radioactive GABA accumulated by rat sensory 
or superior cervical ganglia becomes exclusively localized 
in glial cells (GOTTESFELD, KELLY & SCHON, 1973; YOUNG,
BROWN, KELLY & SCHON, 1973) from whence it can be released 
by high potassium-stimulation in a calcium-dependent manner
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(BOWERY & BROWN, 1972; ROBERTS, 1974; MINCHIN & IVERSEN, 
1974). Subject to these unresolved difficulties, the 
present results demonstrating potassium-stimulated, calcium- 
dependent release of radioactive GABA and glycine from 
tissue slices are consistent with these inhibitory amino 
acids functioning as transmitters at least as early as 
1 day after birth.
The release of radioactive glycine by potassium 
from slices of adult cerebral cortex is interesting in 
view of the relative lack of evidence for glycine acting as 
a synaptic transmitter in this region of the brain (CURTIS 
& JOHNSTON, 1974). 'High affinity' uptake of glycine 
into slices of adult cerebral cortex cannot be demonstrated 
(JOHNSTON Sc IVERSEN, 1971) although a'high affinity', 
sodium-independent uptake is present in synaptosomes prepared 
from the same tissue (PETERSON & RAGHUPATHY, 1973).
Most of the glycine uptake into slices of cerebral cortex 
appears to be mediated by the 'low affinity', ‘small neutral* 
amino acid system which also transports a-alanine and 
aminoisobutyric acid (SMITH, 1967; BLASBERG, 1968).
It does appear from the present release experiments that 
glycine enters, more efficiently than does 2-aminoisobutyric 
acid, a pool from which it can be released by potassium 
stimulation. This pool may represent the glycine taken up 
by the 'high affinity* system which cannot be detected in 
conventional uptake experiments on slices of cerebral cortex.
These experiments were carried out with a simple 
apparatus that has proved convenient and reliable for 
studying the release of radioactive amino acids from mini­
slices of nervous tissue. A similar system may be useful 
for studying the effects of centrally-active drugs on 
transmitter release and for distinguishing between compounds
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that influence amino acid transport by inhibiting uptake, 
potentiating release, or sharing the transport carrier.
Obviously, a rigorous study of development of amino 
acid transmitter function in the CNS must include a combined 
neurochemical, neurophysiological, neuropharmacological, 
anatomical and autoradiographic approach. Work presented 
in the previous three chapters represents the application 
of some current neurochemical ideas and techniques which 
have been helpful in establishing transmitter roles for 
GABA and glycine in the adult CNS, to the problem of the time 
during development when these compounds are first used as 
transmitters in young animals. The data on (1) postnatal levels
of glycine and GABA (2) the presence and characteristics 
of high affinity uptake systems specific for these amino 
acids in CNS slices (3) the susceptibility of young animals 
to convulsions caused by the glycine and GABA antagonists, 
strychnine and bicuculline, and (4) the observation of potassium- 
stimulated calcium-dependent release from CNS slices provide 
circumstantial evidence that these compounds are functioning 
as transmitters at least as soon as 1 day after birth.
VI. THE EFFECT OF SOME DRUGS ON AMINO ACID LEVELS
IN 10-DAY RAT SPINAL CORD
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1. INTRODUCTION
A large number of studies have examined the 
levels of mammalian brain amino acids after administration 
of convulsive drugs. Attempts have been made to correlate 
CNS hyperexcitability with increases in levels of those 
amino acids which excite central neurons when applied 
microelectrophoretically or with decreases in levels of 
those amino acids with inhibitory effects. The discovery 
of compounds which can profoundly raise or lower GABA 
levels has aided in an understanding of GABA metabolism and 
physiology (e.g. WOOD & ABRAHAMS, 1971; KURIYAMA, ROBERTS 
& RUBINSTEIN, 1966).
In the present investigation, a number of drugs 
were tested in 10-day-old rats with the main aim of finding 
compounds which could alter glycine levels in the spinal 
cord and thus aid in studies of glycine metabolism.
10-day-old rats were used for two reasons: (1) the less
developed blood-brain barrier system (JOHNSTON, 1973) and,
(2) the relative ease of injection and removal of spinal 
cord. Changes observed in spinal cord levels of amino acids 
from drug administration were compared with changes in 
brain levels observed in other studies.
2. METHODS AND MATERIALS
Drugs were administered to unanaesthetized 10-day- 
old rats, weighing between 16 and 22 g, by intraperitoneal 
injection of aqueous solutions. Control animals received 
0.9% (w/v) saline and volumes of solutions administered 
were less than 1% of body weight. After the stated times 
(see Table 6.1) the rats were decapitated and spinal cords 
removed and weighed. The procedure for preparation of 
extracts &r amino acid analysis has been described (Section III.2).
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Extracts were analysed on a Beckman amino acid analyser 
using a modified system (JAMES, unpublished results) which 
allows GABA to be simultaneously analysed with aspartate, 
glutamate, glycine and alanine.
Drugs were purchased from the following sources: 
amino-oxyacetic acid (Eastman); cycloserine (Nutritional 
Biochemicals); thiosemicarbazide (B.D.H.); ß-phenyllactate 
and oxythiamine chloride hydrochloride (Sigma); methionine 
sulphoximine (Calibiochem) and Nikethamide (Ciba).
3. RESULTS AND DISCUSSION
Results for seven drugs are presented in
Table 6.1.
Amino-oxyacetic acid. After 3 h, 50 mg/kg amino-oxyacetic 
acid almost doubled GABA levels and reduced the levels of 
glutamate and aspartate in 10-day rat spinal cord. This 
dose of amino-oxyacetic acid, administered to adult rats 
2 h before decapitation, was shown to cause a large accumulation 
of GABA and a decrease in the levels of glutamate, aspartate 
and alanine in the brain (YOSHINO & ELLIOT, 1970). The 
large increase in GABA can be explained on the basis of 
inhibition of GABA:2-oxoglutarate aminotransferase (COLLINS, 
1973); increased levels of inhibitory synaptic transmitter 
may explain the anticonvulsant properties of amino-oxyacetic 
acid (DE VANZO, GREIG & CRONIN, 1961; KURIYAMA, ROBERTS & 
RUBINSTEIN, 1966; TAPIA, DE LA MORA & MASSIEU, 1969).
It appears that amino-oxyacetic acid also affects the 
activity of pyruvate-glutamate and oxaloacetate-glutamate 
transaminases, although we did not observe any significant 
change in alanine levels in 10-day rat spinal cord. Amino- 
oxyacetic acid has been shown to inhibit serine hydroxy- 
methyltransferase (Section II.3) and glycine:2-oxoglutarate
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aminotransferase (JOHNSTON & VITALI, 1969) in vitro. A 
slight decrease in glycine level (p < 0.05) was observed 
in this experiment.
Cycloserine. Cycloserine (50 mg/kg) had the effect of 
increasing the levels of glycine and taurine by about 20%, 
with a smaller, less significant increase in GABA. No 
tremors or convulsions were observed. Cycloserine inhibits 
serine hydroxymethyltransferase activity in vitro (Section 
II.3) as well as other pyridoxal-dependent enzymes, because 
of its ability to bind strongly to pyridoxal phosphate.
Thiosemicarbazide. 2^/2 h after the administration of 
50 mg/kg (0.55 mmole/kg) of this compound there was a 50% 
decrease in GABA levels, with a less significant decrease 
in phenylalanine and increase in glutamine. Slight tremors 
were evident after 1^/2 - 2 h. No significant effect was 
observed on glycine levels. WOOD & ABRAHAMS (1971) have 
examined the effects of various hydrazines on GABA levels 
and metabolism in chick brain. 30 min after injection of 
chickens with 2.5 mmol/kg of thiosemicarbazide, the GABA 
level had dropped by 25%; very similar effects were observed 
with other hydrazides.
DL-6-Phenyllactate. This compound failed to produce any 
significant changes in 10-day spinal cord amino acid levels 
at the dose given. It has been reported to be a specific 
inhibitor of rat liver glycollate oxidase (RICHARDSON, 1973) 
and was tested in view of the possible role of glycollate 
oxidase in glycine synthesis in the CNS (CURTIS & JOHNSTON, 
1974; see Fig. 2.1).
Oxythiamine. An analogue of thiamine, this compound
inhibits the formation of the coenzyme, thiamine pyrophosphate.
Chronic administration results in symptoms of thiamine
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deficiency and eventual death. This substance was tested 
because thiamine-deficient animals have increased levels 
of glyoxylate (LIANG, 1962; BUCKLE, 1963). Elevated 
levels are probably caused by inhibition of the thiamine 
pyrophosphate-dependent, pyruvate dehydrogenase and 
a-oxoglutarate dehydrogenase enzyme complexes, which catalyse 
the condensation of glyoxylate with pyruvate and ü-oxoglutarate 
respectively (KUBASIK, RICHERT, BLOOM, HSU & WESTERFELD,
1973; SCHLOSSBERG, BLOOM, RICHERT & WESTERFELD, 1970). A 
single administration of this drug had no effect on amino 
acid levels.
Methionine sulphoximine. No changes in amino acid levels 
were observed with the low dose used in this experiment, 
although all animals displayed slight and spasmodic tremors.
This compound produces 'running fits' and grand-mal seizures 
in dogs, 16-18 h after i/p administration of 10 mg/kg 
(BROWN & STONE, 1973) . A dose of 2 mmol/kg produced 
convulsions in 10-day-old rats in 4^/2 - 5 h (JOHNSTON,
1973) .
Nikethamide. This drug which has been used as an analeptic 
and as a respiratory and cardiovascular stimulant has 
been shown to cause convulsions in high doses (80 mg/kg) 
(ECKENHOFF & HAFKENSCHIEL, 1947). Nikethamide (50 mg/kg) 
showed no effect after 3 h although all animals showed 
slight tremors before being killed.
None of these drugs produced any large change 
in glycine levels. Cycloserine increased glycine by 22%, 
approximately 2 h after administration (50 mg/kg). Amino- 
oxyacetic acid and thiosemicarbazide were observed to have 
drastic effects on GABA levels, similar to their effects in 
brain. It is suggested that attempts to relate the onset of 
experimentally-induced convulsions with changes in brain 
GABA levels should include measurement of spinal cord levels.
PART TWO,: , D- AND L - ^  PART ATE
VII. THE UPTAKE AND RELEASE OF D- AND L-AS PART ATE
BY RAT BRAIN SLICES
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1. INTRODUCTION
The four most abundant amino acids in the adult 
mammalian brain are glutamic acid, glutamine, GABA and 
aspartic acid. Both L-glutamate and L-aspartate are likely 
to be major excitatory CNS transmitters. The central levels 
of L-aspartate vary from region to region, but only within 
the feline spinal cord have levels been correlated with a 
possible function as a transmitter of excitatory interneurons 
(DAVIDOFF, GRAHAM, SHANK, WERMAN & APRISON, 1967).
L-glutamate, more concentrated in the dorsal than in ventral 
roots of feline spinal cord, has been proposed as the 
excitatory transmitter released by the terminals of primary 
afferent fibres (GRAHAM, SHANK, WERMAN & APRISON, 1967).
In other areas no obvious correlation exists between the 
levels of L-glutamate, activities of its various metabolising 
enzymes and suspected transmitter function (JOHNSON,
1972a, b).
Both L-glutamate and L-aspartate excite feline 
central neurons by a reversible depolarization accompanied 
by an increase in membrane conductance (CURTIS, PHILLIS & 
WATKINS, I960? KRNJEVIC & SCHWARTZ, 1967). The corresponding 
D-isomers are only slightly less potent excitants when 
tested by microelectrophoresis ( CURTIS & WATKINS, 1963;
CRAWFORD & CURTIS, 1964).
In a study on the high affinity uptake of L-aspartate 
and L-glutamate in slices of rat cerebral cortex and feline 
spinal cord, BALCAR & JOHNSTON (1972a, b) showed D-aspartate 
to be a strong inhibitor of L-glutamate and L-aspartate 
uptake; in fact, in rat cortex, it was a stronger inhibitor 
of L-glutamate uptake than was L-aspartate. D-glutamate, 
however, was weaker than the corresponding L-isomer in 
inhibiting L-glutamate or L-aspartate accumulation. This work
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suggested that D-aspartate inhibition of L-glutamate uptake 
was consistent with linear competitive inhibition, but 
did not indicate whether D-aspartate was accumulated by the 
slices (i.e. whether it was a substrate for the dicarboxylic 
amino acid transport 'carrier').
Work reported in this chapter describes the 
preparation of radioactive D-aspartate and its use to 
determine whether D-aspartate was actively accumulated by 
slices, and furthermore, to examine kinetics, substrate 
specificity and subcellular distribution of any such uptake.
2. METHODS AND MATERIALS
Preparation of [^c] D-aspartic acid. [4-^C ] D-aspartic acid
r 1 4  iwas prepared from 4^- CjDL-aspartic acid using an acetone
powder extract of Clostridium welchii (containing L-aspartate
4-carboxy-lyase activity), under conditions similar to those
described by MARGOLIS & LAJTHA (1968). Reaction mixtures,
in Kontes flasks (25 ml), contained 10.8 Mmoles of [i-^c] DL-
aspartate acid (0.05 mCi), 120 Mmoles of soaium pyruvate,
150 mg of Cl.welchii acetone powder and 2 Mmole of L-aspartic
acid in a total volume of 5.2 ml of 0.2 M sodium acetate14buffer, pK 4.9. To collect CO^ evolved, a rolled piece of
Whatman 3MM paper ( 4 x 2  cm), which had been soaked in
3 N potassium hydroxide and dessicated over potassium hydroxide
pellets, was placed in a small plastic cup hanging from the
orubber stopper. Reactions were incubated at 37 C in a shaking-
water bath for 6 1/2 h, then a further 2 Mmoles of
L-aspartate and 30 mg of Cl. welchii extract in 0.2 M acetate
buffer was added and incubation continued for a further
3 h. Reactions were stopped with 1 ml of 4.5 M perchloric
acid and incubated for a further hour before removal of
potassium hydroxide papers for scintillation counting.
14Efficiency of C02 capture by the papers was measured
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simultaneously using flasks containing NaH CO^ . The 
perchloric acid precipitated protein was removed by 
centrifugation and the supernatant neutralized with potassium 
hydroxide. Potassium perchlorate was removed by centrifuation 
and the supernatant concentrated in vacuo to approximately 
3 ml. This was loaded onto a small column of Dowex 1 x 8  
(acetate form; 200-400 mesh, 5 ml of resin, I.D. of column =
7 mm). Columns were washed with 45 ml of water, 20 ml of 
0.1 N acetic acid, 50 ml of 0.4 N acetic acid and then with 
2 N acetic acid. The peak of radioactivity was eluted with 
0.4 N acetic acid; these fractions were pooled, reduced to 
dryness in vacuo several times to remove acetic acid and 
then aliquots were subject to a second incubation with Cl. 
welchii extract to check on the completeness of L-aspartate 
digestion. Less than 3% of added radioactivity was released 
as 14C02.
14
Aspartic acid uptake by tissue slices. The procedures used
r 14 1for measuring the uptake of 4- CjD-aspartic acid and
L-aspart.ic acid were essentially the same as those3U- H
described in a previous chapter (Section IV.2). All experiments,
ounless otherwise stated, were carried out at 25 C. For 
kinetic analysis, initial velocities of aspartate accumulation 
at ten concentrations of substrate in the range of 9-400 pM 
were determined. Cold substrate (100 pi) was added at the
same time as the radioactive substrate (100 pi). Potential
-4inhibitors (10 M) were preincubated with the slices for 
15 min before the addition of radioactivity. All experiments, 
including the blank (not incubated) were done in quadruplicate. 
Slices, on filter paper discs, were extracted with water 
for 1 h at room temperature, then 10 ml of scintillator 
(either 0.5% PPO and 10% napthalene in dioxan or 0.3% PPO 
in a 1:3 mixture of Triton X-114:xylene) added and 
radioactivity measured in a scintillation counter (Beckman 
LS-100). Counts per minute (CPM) were converted to 
disintegrations per minute (DPM) by means of an external 
standard.
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Density gradient fractionation of accumulated radioactivity. 
The procedure used was similar to that described by ARREGUI, 
LOGAN, BENNETT & SNYDER (1972). All operations were performed 
at 0-4°C. The cerebral hemispheres of 13-week-old rats 
were separated from the midbrain, cerebellum and pons-medulla, 
dissected free of underlying white matter and homogenized in 
20:1 (v/w) 0.32 M sucrose by 12 up-and-down strokes of a 
motor-driven perspex pestle (rotating at 870 rev./min, 
clearance 0.25 mm difference in diameter) in a stainless- 
steel homogenizer. The homogenate was centrifuged at 1000 x 
g. for 10 min to remove nuclei and cell debris and 1.5 ml 
aliquots of the supernatant were added to Kontes flasks 
(25 ml) containing 15 ml of oxygenated Krebs Ringer phosphate 
buffer, pH 7.4. After preincubation at 37°C for 5 min in
a shaking water bath, radioactive amino acids (1 jaCi of
14 3[ c]D-aspartate and 1.5 pCi of [ H]L-aspartate) were added
and incubation continued for 5 min. Contents of flasks were
cooled on ice and transferred to 40 ml centrifuge tubes over
a layer of 10 ml of ice-cold 0.32 M sucrose. Tubes were
centrifuged at 27,000 x g. for 5 min to form a crude
mitochondrial pellet. The pellet was rinsed with 10 ml of
cold sucrose and thoroughly suspended in 3 ml of 0.32 M
sucrose using a pasteur pipette and vortex mixer, taking
care to eliminate particle aggregates. In one experiment,
the pellet was osmotically shocked by resuspension in water
instead of 0.32 M sucrose. The suspension was layered on
a continuous sucrose density gradient formed by linear
dilution of 13 ml of 1.5 M sucrose with 13 ml of 0.5 M
sucrose. Gradients were prepared at room temperature and
left in the cold room (4°C) for 4-5 h. These were
centrifuged at 53,000 x g. for 1 h with a SW 25.1 head in an
ultracentrifuge (Spinco, model L). Fractions were obtained
56
by piercing the bottoms of the tubes and collecting 20-drop 
fractions directly into scintillation vials. P h ] and 
[14c] radioactivity was determined after the addition of 
3 ml of Bray's scintillator. Results were corrected for 
spillover of [44c] CPM into the [ ^ h ] channel.
Release of aspartic acid from slices. The apparatus and 
procedure for release studies has been described previously 
(Section V.2). Adult rat cortex slices were preloaded with 
^ 4c ]d - or ' 3,xljL-aspartic acid for 20 min, then filtered 
onto glass fibre filter discs and transferred to the perfusion 
apparatus. Initial perfusion time before perfusion with 
high potassium buffer was 25 min. 10 min perfusion with high 
potassium was followed by a return to normal buffer for 25 
min. Fractions of superfusate were collected every 2.3 min 
directly into scintillation vials and radioactivity determined 
after the addition of 9 ml of xylene:Teric N8 scintillator 
(see Section V.2).
Metabolism. Rat brain cortex slices (100 mg) were 
incubated in 10 ml of oxygenated Krebs ringer phosphate 
buffer at 37°C in a shaking water bath for 1 h, in the 
presence of L-aspartate or [4%c]D-aspartate. The slices
were collected by centrifugation and the extracts 
concentrated to dryness in vacuo. Extracts were 
resuspended in 200 pi of water and 50 P 1 aliquots subject
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to electrophoresis on paper strips in 2% pyridine, 1% acetic 
acid, pH 5.2 at 300 V for 21/2 h. Strips were cut into 1 cm 
pieces, placed in scintillation vials with 1 ml water for 1 h, 
then scintillator added and radioactivity determined.
The radioactivity retained in cerebral cortical 
slices at the end of perfusion experiments was examined.
Tissue was homogenized in 5 ml of 0.45 N perchloric acid in 
a glass-teflon homogenizer and the supernatant collected 
by centrifugation. The extract was neutralized with potassium 
hydroxide, the potassium perchlorate removed by centrifugation 
and the supernatant concentrated in vacuo. The extract 
(acidified to pH 1-3) was applied to a small column of Dowex 
50W x 4 (200-400 mesh), washed with 0.01 N HCl and water, 
then eluted with 2N ammonia. A 1 ml aliquot of the wash 
was counted to determine radioactivity in acid metabolites, 
while the 2 N ammonia eluent was evaporated to dryness 
in vacuo (several times to remove ammonia), resuspended 
in a small volume of water and subjected to electrophoresis 
on paper strips under the conditions described above.
14Chemicals. [4- C]DL-aspartic acid (4.64 mCi/mmol) was
3purchased from I.C.N., Cleveland, lu- H]L-aspartic acid
14(2.2 Ci/mmol) from New England Nuclear, Boston, and [ c] 
sodium bicarbonate (42.4 mCi/mmol) from the Radiochemical 
Centre, Amersham. Other chemicals were purchased from the 
following sources; L-aspartic acid, sodium pyruvate and 
L-glutamate decarboxylase (crude acetone powder from 
Clostridium welchii, containing L-aspartate 3-decarboxylase 
activity) (Sigma); D-glutamic acid, threo- ß-hydroxy-DL- 
aspartic acid and L-cysteinesulphinate (Calbiochem); 
D-aspartic acid (Nutritional Biochemicals); monosodium 
L-glutamate (B.D.H.); L-cysteic acid (Light and Co.); 
amino-oxyacetic acid (Eastman); and sucrose (Mann).
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N-methyl-L-aspartic acid and N-inethyl-D-aspartic acid were 
prepared by Dr J.C. Watkins (WATKINS, 1962).
_3_.__RESULTS
Time course of D- and L-aspartate uptake. Adult rat brain
cortex slices were preincubated at 25°C for 5 min, radioactivity
added and incubation continued for different times before
the slices were filtered and washed with saline. The time
14 3course of uptake of [4- c]D-aspartate and [u- H]L-aspartate
is illustrated in Fig. 7.1. The specific activity of the 
14[ c]D-aspartate used was 4.6 mCi/mmol; approximately 
0.1 pci of radioactivity was used per incubation vial, 
giving a final concentration of 2 in the 10 ml of incubation 
medium. The specific activity of the L-aspartate was 2.2 
Ci/mmol; approximately 0.22 pci was used per bottle, giving 
0.01 pM. Assuming the endogenous concentration of L-aspartate 
in the rat cortex to be 2 pmol/g wet weight and that 50% 
of this is released on preparation of slices (BALCAR &
JOHNSTON, 1975), the contribution to the external L-aspartate 
concentration from endogenous L-aspartate is 1 pM. With these 
concentrations of D-and L-aspartic acid it can be seen that 
D-aspartic acid is accumulated to a greater extent than the 
L-isomer, with uptake linear for a longer period of 
time. In most subsequent experiments, unless otherwise 
stated, L-aspartic acid uptake was measured over 5 min and 
D-aspartate over 10 min.
Kinetics of D- and L-aspartate uptake. The initial rates 
of accumulation of D- and L-aspartic acid were measured in 
adult rat brain cortex slices over a range of aspartic acid 
concentrations from 9 to 400 pM. For L-aspartic acid uptake, 
analysis of the data by the method of CLELAND (1963) revealed 
a 'high affinity' system with a K^ of 15.6 - 2.1 pM and a
\
14Fig. 7.1. Time course of accumulation of radioactive [ C]D-aspartate 
and [^ hIl-aspartate in slices of adult rat cerebral cortex. Slices 
were preincubated at 25°C for 5 min, radioactivity added and 
incubation continued for different times before slices were 
filtered and washed with saline. The tissue to medium ratio is 
the CPM accumulated per ml of tissue water/CPM per ml of 
incubation medium; in this case the parameter was calculated 
assuming the tissue to be 100% water.
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of 0.10 - 0.007 ymol/min/g wet weight, and a 'low affinity'
uptake with a K of 125 - 14 jJM and a V of 0.25 - 0.01 m m
ymol/min/g wet weight. Analysis of D-aspartate uptake
revealed only a 'high affinity* system of lower K to that
+ mfor L-aspartate, i.e., K = 7.5 - 1.3 yM, and with a higherm
maximal velocity of uptake of 0.22 - 0.01 ymol/min/g 
(Fig. 7.2) .
Sodium-dependence of D-aspartic acid uptake, in common with 
high affinity uptake of the transmitter candidates L-aspartate, 
L-glutamate, GABA, proline and glycine (in the spinal cord), 
the uptake of D-aspartate was completely dependent on the 
presence of sodium . The absence of sodium resulted 
in radioactive accumulation not significancly different from 
zero time blank values (Fig. 7.3). In another experiment, 
the 118.1 mM sodium chloride was replaced with lithium 
chloride or choline chloride and the ability of lithium to 
support uptake in the absence of sodium was examined (Table 
7.1). Uptake of D-aspartate in the presence of lithium was 
about 4% of that in the presence of sodium, and was 4-5 times 
more than the value for L-glutamate uptake. GABA uptake 
was not significantly different from the CPM accumulated 
in the absence of sodium.
Inhibitors. Several amino acids and analogues were tested
-4at 10 M concentration against D- and L-aspartate uptake 
(Table 7.2). The pattern of inhibition of the D- and 
L-isomers was similar. D-glutamate showed significant 
inhibition of D-aspartate uptake (27 - 5%) and no significant 
inhibition of L-aspartate uptake, while D-aspartate was a 
better inhibitor of L-aspartic acid uptake than was the 
L-isomer itself. D-glutamate was less effective in inhibiting 
either D- or L-aspartate than was L-glutamate.
Fig, 7.2. Kinetic analysis of data for the uptake of D- and 
L-aspartate in slices of adult rat cerebral cortex. The slices 
were preincubated for 5 min at 25°C before addition of radioactive 
substrate and incubation continued for a further 5 min for 
L-aspartate or 10 min for D-aspartate. Each point represents 
the mean - S.E.M. of 3-4 experimental values. Each set of 
points represents a separate experiment. The open circles are 
derived from measurements of initial velocities of L-aspartate 
accumulation over a range of external L-aspartate concentrations 
from 9-81 yM, the closed circles from L-aspartate accumulation 
over the concentration range 81-400 yM, while the black squares 
are from measurements of D-aspartate accumulation over the 
concentration range 9-81 yM. The lines represent Lineweaver- 
Burk plots of the computed best fit of the individual experimental 
values obtained in each experiment, to the hyperbola v = VA/(.K + A) 
(CLELAND, 1963), for the range of substrate concentrations given. 
The units of uptake velocity, v, are ymol/min/g wet weight 
and those of A, the external substrate concentration, are yM.
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Fig. 7.3. Analysis of the dependence on external sodium 
ion concentration of [^c] D-aspartate (2 yM) uptake into 
adult rat cerebral cortex slices. Slices were preincubated 
at 25°C for 15 min before the addition of radioactive substrate 
and uptake measured after 10 min. Uptake was measured in 
medium in which the normal sodium phosphate buffer was replaced 
with tris-HCl buffer and in which varying proportions of the 
sodium chloride were replaced with choline chloride. The 
points are means ^ S.E.M. of 4 determinations and uptake is 
expressed as the percentage of uptake observed at 118.1 mM 
sodium.
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Table 7.2. Inhibition of the high affinity L-aspartate 
and D-aspartate uptake into adult cat cortex slices
% Inhibition of control uptake
Inhibitor (10 M)_____________ L-aspartic acid D-aspartic acid
Threo-3-hydroxy-DL-aspartate 101 - 1 8 9 - 2
L-cysteinesulphinate 8 7 - 1 9 5 - 1
+ +L-cysteate 8 9 - 1 9 0 - 1
L-aspartate 7 8 - 2 8 3 - 4
D-aspartate 8 9 - 1 8 2 - 1
L-glutamate 7 4 - 2 6 6 - 1
D-glutamate n. s. 2 7 - 5
N-methyl-L-aspartate n. s. n. s.
N-methy1-D-aspartate n. s. n.s.
The tissue slices were preincubated with the amino acids at
the concentration shown for 15 min at 25°C, [^H]L-aspartate
14(0.02 UM) and [ c ]D-aspartate (2.0 uM) added and uptake
measured after 10 min. Values are means - S.E.M. of results
from quadruplicate experiments. In double-label scintillation 
r 3 !counting, l HJ CPM were corrected for spillover from the 
[14C] channel.
bü
Subcellular distribution of accumulated radioactivity. 
Homogenates of rat cerebral cortex were incubated with 
l^H]L-aspartäte and [^CJD-aspartate, the crude mitochondrial 
fraction separated by centrifugation and subjected to density 
gradient fractionation on a sucrose gradient. Both D- and 
L-aspartate appear to be accumulated into the same subcellular 
particles, since peaks of radioactivity were not separable 
on sucrose density gradients (Fig. 7.4). Both isomers were 
accumulated into osmotically-sensitive particles, since 
suspension of the crude mitochondrial pellet in water instead 
of 0.32 M sucrose, prior to applying it to the top of the 
gradient, resulted in release of radioactivity into the 
medium. In repeated experiments it was observed that there 
was always less of the total radioactivity from D-aspartate 
at the top of the gradient (i.e. radioactivity released 
from particles in the crude mitochondrial pellet during 
suspension and layering on the gradient) than there was 
of the L-aspartate radioactivity. To examine further the 
efflux of aspartate from sites of accumulation, release of 
D- and L-aspartate was followed, using apparatus previously 
described (Section V.2) for studying the release of GABA 
and glycine.
Release of D- and L-aspartic acid. Cerebral cortical slices
14 3were preloaded with [4- c]D-aspartate and [U- H]L-aspartate 
at 37°C. Slices were perfused with normal buffer for 25 min 
before switching to high potassium buffer for 10 min.
In two experiments (slices prelabelled either in the presence 
or absence of 2 x 10 M amino-oxyacetic acid) D-aspartate 
was released with very little release of L-aspartate. 
Increasing the initial perfusion time to 40 min before the 
potassium-stimulation did result in release of L-aspartate; 
this however, was still much less than that observed for
Fig. 7.4. Subceliular distribution of radioactive [^ h Jl- 
aspartate and [^^c]D-aspartate accumulated by homogenates 
of adult rat cerebral cortex. Homogenates were incubated 
with radioactive D- and L-aspartate for 5 min, the crude 
mitochondrial fractions separated by centrifugation and 
subjected to density gradient fractionation on sucrose 
gradients formed by linear dilution of 13 ml of 1.5 M sucrose 
with 13 ml of 0.5 M sucrose. Gradients were centrifuged 
at 53,000 x g. for 60 min in a swinging-bucket rotor. The 
closed circles are an experiment in which the crude 
mitochondrial pellet was suspended in 0.32 M sucrose prior 
to density gradient fractionation. The open circles are an 
experiment in which the crude mitochondrial pellet was 
osmotically shocked by resuspending in water instead of 
0.32 M sucrose, before being layered onto the sucrose 
gradient.
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D-aspartate (Table 7.3). It was also apparent from these
14perfusion experiments that [ c ]D-aspartate radioactivity
r 3 .was retained to a much greater extent than I HJL-aspartate 
radioactivity (Table 7.3). To determine the reason for 
lack of release of L-aspartate the extent of metabolism 
was examined under the same conditions.
Metabolism. Under the conditions of the uptake experiments, 
with 5 min incubation for L-aspartate, less than 10% was 
metabolised (BALCAR & JOHNSTON, 1972a). Analysis of 
radioactivity accumulated by rat brain cortex slices (100 mg) 
after 1 h incubation at 37°C with [^ H] L-aspartate or [^c]D- 
aspartate in 10 ml of Krebs ringer phosphate buffer showed 
that of the CPM recovered from electrophoresis strips, 
more than 97% of D-aspartate radioactivity ran as aspartate 
(two experiments), while only 66-72% of radioactivity from 
L-aspartate ran as aspartate (two experiments). Under 
conditions of the perfusion experiments, with 20 min preloading 
of tissue with radioactive compound and subsequent perfusion 
for 50-65 min, an examination of radioactivity retained in 
the slices at the end of perfusion showed that between 46% and 
71% of the L-aspartate was metabolised. There was less 
than 3% metabolism of the D-aspartate.
Kinetics of inhibition by the opposite isomer. Data from
two separate experiments, in which the kinetics of L-aspartate
accumulation were examined in the presence of 13.3 and 26.7
PM D-aspartate, were fitted to the equation for linear
competitive inhibition (CLELAND, 1963; BEART, JOHNSTON &
UHR, 1972). The following results were obtained (weighted
mean - S.E. of the weighted mean, for values - S.E. of the
kinetic constants from the two experiments; see Appendix 2):
K = 1 7 . 3 - 1 . 8  pM; V = 0.10 - 0.006 pmol/min/g wet m m
weight; K^ = 13.0 - 0.9 pM. Data from three experiments,
Ta
bl
e 
7.
3.
 
Re
le
as
e 
of
 r
ad
io
ac
ti
ve
 a
sp
ar
ta
te
 f
ro
m 
ra
t 
ce
re
br
al
 c
or
te
x 
sl
ic
es
£
ft G
u 0 0
P •H
13 CO -P 0 1
0 CO 0 0  U 0
P •H rH G 0 G G
0 P LO CTi CN P -H G 0 •H
rH • • • • • E -H W P  £
P o rH i—i rH O •H C 0 0 0 0
£ 13 -P £  -P P
P + 1 +  1 +  i + 1 +  1 0 O 0 a 0 P
o 13 1 rG P u 0
u CD CO rH m ID cn 0 0 0 G
0 G cn cn m in m P >1 13 0 0
•H a  0 p  -p 0 u
P rd -P -H 13 G
G P 0 G >  G 0 0
0) o -p 0 *H *H 0
u p 0 E -P 0 0
p •H ‘H U 0 13 P
0 13 P 0 0 P  f t
ft 0  0 0 E
£  f t ‘H p G 0
E X H 0 •H 13
•H 0 0 P P
P P 13
P P  0 0 G
CO 0 0  D Oh 13 -H
QJ '—■ > 0 0
0 0 P -p 0 0 13
0 "d1 0 0 -P -H 0
0 + i—l 0 13 rH G 0 13
r—1 CN 0 E P 0 P 0
0 rd + 1 I I l i 0  P E E f t 0
P U 0 G P -H rH
1 cr> rH U P 0 0
15 0 0 u 0 P P
0 P rG 0 a 0 f t
P -P X £
0 G P  0 0
r—1 -H 4H 0 0 p
P 0 0 0 0
E 0 0 13 u S
•H 0 • Cn P •H
P 0 £  0 rH 0
0 0 • P  P 0 0
» P W C 0 u
E _ _ ._ U • 0 P 0 *H
P G 03 U 13 rH
•H '—• »—' —- — —- •H P 0 p 0
0 + 1 0 P
0 1—1 m CO r* ID 0 a  0 rG *
0 + 00 Cn 0 u 0
P CM 0 G 0 13 •H P
0 rd +1 + 1 + l + 1 + 1 P  0 13 G rG G
f t u G 0 P  0 £ 0
+ r* o in o i—1 0 E E
rH CN rH co u 0 G *H
CN CN P 0 £ G •H P
G 0 P 0 0 0
0 f t 0  rG -H P  f t
•H 0 0 G X
CO X  C  P 0 0
p 0 0 G P E
p G 0 > E P •H P
P •H f t  -H P 0 P 0
0 E * * Cn rH f t 0 rG
Q in in in in o 0 0 f t  P
CN CN CN CN 13 0 U P X 0 •
■— 0 P  0 0 0
rd E p 13 G £
•r- •H 0  H  C 'O G Pin
P p 0 0 0 G 0
■c >  13 0 0
G 13 1 P • rH
H 0 P  0 O 13
P  * 13 rG P  -H X
0 X Cn P u
rH p -H 0 0 CN
P rH P p P —r
U P  0 0 U
.H P  0 •H 13
0 0  ,C 0 0 P ■H
U E-t <D 0 0 U
0 0 0 U • P u 0
13 -P -P 0 P -H E •H 0
•H rd 0 "H O  • rH p 0  > 1 Uu -P -P 0 0 0 •H >  X •H
rd P P 0 G P u O P
rd 0 0 0 0 0 1—1 0 1 0
0 ft ft 0 P  rX ,G 0 0 0 U
c CO 0 0 G U P U 0 G 0
•H 0 0 rH 0 0 rG -H
g 1 1 0 f t p >1 p X
<! Q i-3 03 0 13 13 0 *  0 0
62
in which the kinetics of D-aspartate accumulation were 
examined in the presence of several concentrations of 
L-aspartate were variable, possibly because of metabolism 
of the L-aspartate occurring over the time of preincubation 
and then incubation with radioactive D-aspartate.
4. DISCUSSION
The uptake of D-aspartate was linear for at least 
10 min, whereas that of L-aspartate levelled off after 
5 min. This was presumably due to metabolism and release 
of metabolites into the medium. Release experiments showed 
that D-aspartate radioactivity was retained to a much 
greater extent than radioactivity from L-aspartate.
Lineweaver-Burk plots of the dependence of aspartate
uptake on the external concentration of aspartate showed
two kinetically distinct systems for L-aspartate accumulation.
This has been shown to be the case for L-glutamate, L-aspartate
and glycine uptake in cat spinal cord slices (BALCAR &
JOHNSTON, 1973). The for the high affinity uptake into
rat brain slices (16-2 yM) was very similar to that measured
in cat cord slices (13 - 4 PM). The K for low affinity
+ m +uptake in rat brain slices was 125 - 14 yM, and 185 - 143 pM
for cat spinal core slices. D-aspartate accumulation
measured over the range 10-400 yM showed only a high
affinity uptake, with a K somewhat lower than that form
L-aspartate and with a maximal velocity of accumulation 
approximately twice that for the L-isomer. This difference 
may explain why D-aspartate is a slightly less effective 
neuronal excitant than L-aspartate, when tested by 
microelectrophoresis.
The specificity of a transport system, presumably 
determined by the attachment of the transport substrate to
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the binding site of the carrier, is usually characterized 
by competitive inhibition between analagous substrates.
The presence of competitive inhibition between D- and L- 
aspartate, which are both transported, suggests that they 
use the same transport system. A more rigid proof stipulates 
that the following requirements must be fulfilled if two 
substrates (A and B) use the same transport system (HEINZ,
1967) :
1. The inhibitory constant (K_^ ) of A with respect
to B must be the same as the K of A.m
2. The inhibitory constant of B with respect to A
must be the same as the K of B.m
3. A competing third substrate must have the same 
inhibitory constant with respect to either A or
B.
Results obtained here satisfy one of the first two requirements
and while K. values for a third substrate he je not been is
calculated against D- or L-aspartate uptake, the observed 
inhibitions of uptake of the two isomers by fixed 
concentrations of a number of inhibitors are similar.
The pattern of dependence of rat cerebral cortex 
high affinity D-aspartate uptake on external sodium ion 
concentration was very similar to that observed for 
L-glutamate measured under the same conditions (BALCAR & 
JOHNSTON, 1972a). In the presence of approximately 1 pM 
D-aspartate, half-maximal uptake was calculated to occur 
at an external sodium ion concentration of 14 - 2 mM, 
which is the same as that for L-glutamate uptake (13-5 mM; 
external L-glutamate concentration approximately 3.6 MM).
A comparison with the sodium-dependence curves for GABA 
and glycine high affinity uptake (Figs 4.1 and 4.2), measured 
under the same conditions, reveals very different patterns,
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with glycine showing a sigmoidal-shaped curve and GABA 
being much more sensitive to changes in external sodium 
concentration. The sodium-dependence curves for high 
affinity L-glutamate and glycine uptake into synaptosomes 
(BENNETT, LOGAN & SNYDER, 1973) are exactly the same as 
have been obtained with slices.
MARTIN & SMITH (1972) have reported a sigmoidal 
sodium-dependence curve for GABA uptake into synaptosomes, 
although in the present results on slices, thr.s is only 
apparent in tissue from immature rats. The fact that the 
uptake of amino acids which have excitatory effects on neurons 
is less sensitive to reduction in external sodium ion 
concentration and can function maximally at sodium ion 
concentrations above about 30 mM, may be relevant to the need 
for uptake to function efficiently during extracellular 
decreases in sodium ion concentration resulting from 
inwardly-directed sodium ion fluxes occurring during post- 
synaptic depolarization (BALCAR & JOHNSTON, 1972a). 
Postsynaptic hyperpolarization by GABA or glycine does not 
involve sodium ion movements (CURTIS & JOHNSTON, 1974) and 
uptake processes necessary for termination of inhibitory 
transmitter action are not required to function efficiently 
at low sodium ion concentrations.
The effects of lithium on the uptake of glutamate, 
aspartate and GABA are qualitatively similar to those 
obtained by PETERSON & RAGHUPATHY (1974) on uptake into 
synaptosomal fractions. Quantitative differences are 
probably explained by the use of slices instead of 
synaptosomes and the presence, in the medium used in the 
current experiments, of calcium, magnesium and potassium? 
PETERSON & RAGHUPATHY reported that the presence of magnesium 
lowered the ratio of Li/Na-supported uptake. From these
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experiments it would seem that the mechanism of glutamate 
and aspartate uptake may not be quite the same, although 
their sodium-dependence curves are very similar. It would 
appear that lithium supports D-aspartate uptake to a 
similar extent as it does L-aspartate.
The uptake of D- and L-aspartate was inhibited 
by structurally-related amino acids bearing one amino and 
two carboxyl or equivalent groups. Substituents on the 
amino group abolished inhibition. As discussed previously 
(BALCAR & JOHNSTON, 1973), the high affinity uptake and 
postsynaptic action of aspartate (and glutamate) are 
different processes, since the strong excitants, N-methyl-L- 
aspartate and N-methyl-D-aspartate had no influence on 
uptake of the natural transmitters. D-aspartate appeared 
to be slightly more effective in inhibiting L-aspartate 
uptake than the L-isomer. D-aspartate was also more effective 
than L-aspartate in inhibiting L-glutamate uptake (BALCAR 
& JOHNSTON 1972a, b). D-glutamate was weaker than 
L-glutamate in inhibiting uptake of L-glutamate (BALCAR 
& JOHNSTON, 1972a, b), L-aspartate and D-aspartate. Briefly, 
the order of potency against uptake of L-aspartate,
D-aspartate and L-glutamate is D-aspartate, L-aspartate, 
L-glutamate and D-glutamate, with the latter being 
substantially weaker than the first three. With respect 
to excitation by these compounds when tested by micro­
electrophoresis, both L-glutamate and L-aspartate had 
similar potencies when tested on spinal interneurons and 
cortical neurons; the corresponding D-isomers were only 
slightly less effective, with the D-aspartate being slightly 
more potent than D-glutamate on cortical neurons (CRAWFORD 
&c CURTIS, 1964; CURTIS & WATKINS, 1963) : on cortical
neurons, KRNJEVlt & PHILLIS (1963) have found D-glutamate
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to be consistently less effective than the L-form, while 
D-aspartate is not very different in potency from L-aspartate.
D-aspartate and L-aspartate appear to be taken 
up into the same osmotically-sensitive subcellular particles 
of crude cortical homogenates. Potassium-stimulation 
caused the release of both isomers, although the extent 
of release of the L-isomer was very low# presumably because 
of extensive metabolism occurring during the course of the 
experiments.
From experiments described in this chapter it 
appears that D-aspartate is actively accumulated by rat 
CNS tissue slices, shares the same transport system as 
L-aspartate, is accumulated at the same subcellular sites as 
L-aspartate, is absolutely dependent on the presence of sodium 
for uptake to occur and shows the same sodium-dependence 
pattern as L-glutamate. it is released from tissue slices 
in response to potassium depolarization, provided calcium 
is present in the perfusing buffer. In fact, radioactive 
D-aspartate may prove very useful in examining the 
neurotransmitter role of the naturally-occurring L-aspartate, 
its main advantage being that it does not undergo rapid 
metabolism. Studies on the autoradiographic localization 
of radioactive D-aspartate may help in determining sites of 
high affinity uptake of L-glutamate and L-aspartate. Such 
information could be of great value in identifying those 
neurons using these compounds as excitatory transmitters.
To date no electron-microscopic autoradiographic studies 
on the localization of sites of high affinity uptake of 
the dicarboxylic excitatory transmitters have been reported 
(IVERSEN & SCHON, 1973).
VIII. D-ASPARTATE OXIDASE ACTIVITY IN EXTRACTS OF
MAMMALIAN CENTRAL NERVOUS TISSUE
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1. INTRODUCTION
The well known D-amino acid oxidase (D-amino-acid: 
oxygen oxidoreductase (deaminating), EC 1.4.3.3), a 
flavoprotein occurring especially in kidneys, oxidises 
many D-amino acids, but has no action on the dicarboxylic 
acids, D-aspartate and D-glutamate (DIXON & KLEPPE, 1965) . 
These two amino acids, however, are oxidised by kidney 
extracts; the enzyme responsible for these oxidations 
is D-aspartate oxidase (D-aspartate:oxygen oxidoreductase 
(deaminating), EC 1.4.3.1) (DIXON & KENWORTHY, 1967).
D-amino acid oxidase activity has been described 
in extracts of mammalian central nervous tissue (NIEMS, 
ZIEVERINK & SMILACK, 1966; GOLDSTEIN, 1966). DeMARCHI & 
JOHNSTON (1969) have measured this activity in different 
regions of the mammalian CNS, particularly the spinal cord, 
because of its possible involvement with glycine metabolism.
Investigations on the extent of metabolism of 
L- and D-aspartate accumulated by tissue slices of rat 
brain, carried out concurrently with uptake studies on these 
compounds, prompted further work to see if the mammalian 
brain contained D-aspartate oxidase, particularly since 
DeMARCHI & JOHNSTON (1969) observed significant uptake of 
oxygen by sheep cerebellum extract in the presence of 
60 mM D-aspartate. During the course of these investigations 
YUSKO & NIEMS (1973) presented evidence for the broad 
distribution of D-aspartate oxidase activity in hog brain 
and noted that the activity was also detected in cat brain.
2. METHODS AND MATERIALS
Enzyme assays. The activity of D-aspartate oxidase was 
measured by either of two assays. The first, used in initial 
studies with the cat and rabbit kidney enzyme, was performed
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essentially by the method of DIXON (1970), using ferricyanide 
as acceptor and following its reduction with a recording 
spectrophotometer (Varian Techtron, model 635) at 420 nm. 
Reaction mixtures contained in a Thunberg cuvette (1 cm 
light path) consisted of 6.67 mM D-aspartate, 83 mM potassium 
phosphate buffer, pH 7.6, 16.7 yM FAD, 0.76 mM potassium 
ferricyanide and 0.1 ml of enzyme extract in a final volume 
of 3.0 ml. Initially the ferricyanide was contained in the 
hollow stopper. After evacuation of the cuvette using a 
water pump and a 15 minute preincubation period, the reaction 
was initiated by inverting the cuvette and mixing the 
ferricyanide with the other reactants. The assay was 
performed at 30°C.
The second method involved the determination of 
the product 2-oxo-acid, oxaloacetate in the case of D-aspartate, 
as the 2,4-dinitrophenylhydrazone (NIEMS, DeLUCA & HELLERMAN, 
1965) . Assays were performed open to the air at 37°C in a 
shaking water bath. Reaction mixtures consisted of 76 mM 
sodium pyrophosphate buffer, pH 8.5, 10 yM FAD 40 yg catalase 
and 20 mM D-aspartate (or other substrate), and up to 0.3 ml 
of extract in a final volume of 1.0 ml. The enzyme was 
pre-incubated with FAD for 15 min before initiation of the 
reaction by addition of substrate. Reactions were stopped 
with 0.2 ml of 50% trichloroacetic acid and centrifuged.
Product oxo-acids were determined on 1.0 ml aliquots of the 
supernatants by addition of 0.1 ml of 0.2% 2,4-dinitrophenyl- 
hydrazine in 2 N HCl, incubation at 37°C for 30 min, then 
reading absorption at 416 nm (KATSUKI, YOSHIDA, TANEGASHIMA 
& TANAKA, 1971) in a micro-sample spectrophotometer,
(Gilford, model 300-N) 10 min after the addition of 0.5 ml 
of 5 N NaOH. D-amino acid oxidase was assayed in a similar 
way, using 20 mM D-alanine as substrate. Substrate blanks 
were run as controls.
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Preparation of tissue extracts. The enzymes were measured 
in water extracts of acetone powders. The tissue was 
homogenized in 10-20 volumes of acetone at approximately 
—10°C in a Waring blendor. The homogenate was centrifuged 
at 1000 g for 3 min at 0°C and the supernatant decanted.
The sediment was washed twice with 5 volumes of acetone.
The powder was air dried while kept cold on dry ice, then 
dessicated in vacuo over NaOH pellets and paraffin wax 
shavings (McILWAIN & RODNIGHT, 1962).
Water extraction involved stirring with 50 volumes 
of ice-cold water for 30 min, then centrifugation to remove 
undissolved material. Ammonium sulphate was added to the 
supernatant to give the desired saturation and stirred for 
20 min at 0°C before collecting the precipitate by 
centrifugation at 27000 g for 20 min.
Protein assays. Protein concentrations in the tissue 
extracts were measured by the method of LOWRY, ROSEBROUGH, 
FARR &c RANDALL (1951).
Chemicals. Reagents were purchased from the following 
sources: D-aspartate (Nutritional Biochemicals); GABA,
L-glutamine, L-aspartate, catalase (partially purified,
1500 units/mg), malonic acid and hog-brain acetone powder 
(Sigma); D-a-alanine, D-serine (Fluka); Glycine (Mann); 
D-asparagine and D-glutamine (Cyclo Chemicals); FAD, FMN, 
L-a-alanine and D-glutamate (Calbiochem); 2,4-dinitrophenyl-
hydrazine, L-glutamate, sodium benzoate, malic acid, 
D-tartaric acid and sodium barbitone (BDH); and potassium 
ferricyanide (May & Baker). The N-substituted aspartic 
acid derivatives were prepared by Dr J.C. Watkins (WATKINS, 
1962) .
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3. RESULTS
Using the ferricyanide assay, no D-aspartate 
oxidase activity was observed in water extracts of acetone 
powders of cat and rat CNS tissue, although activity was 
readily observable in cat and rabbit kidney extracts. With 
the 2,4-dinitrophenylhydrazine assay, however, activity 
which was linear with respect to time and amount of added 
protein (Fig.8.1) was found in ammonium sulphate fractions 
of water extracts of acetone powders prepared from cat, rat, 
hog and sheep brain. Using crude water or buffer homogenates 
of CNS tissue it was not possible to unequivocally demonstrate 
the existence of enzyme activity because of high background 
colour formed as a result of endogenous oxo-acids.
Sensitivity of the assay procedures. A cat kidney extract 
was assayed using both assay procedures. Under the assay 
conditions described in the methods, and with amounts of 
extract chosen to give accurate measure of initial velocities 
in each of the two assays, it was found that the ferricyanide 
assay, using K^Fe(CN)^ as electron acceptor, gave an optical 
density change at 420 nm of 0.030 per min per mg of protein 
whereas the 2,4-dinitrophenylhydrazine assay, in which 
molecular 0^  acted as an electron acceptor, gave an optical 
density change at 416 nm of 0.464 per min per mg of protein 
(taking 1.0 ml of the 1.2 ml assay supernatant). Presumably 
the sensitivity of the ferricyanide assay could have been 
increased by increasing the pH (7.6 to 8.5), the substrate 
concentration (6.67 to 20.0 mM) and the temperature (30°C 
to 37°C), but under the conditions used, the 2,4-dinitrophenyl- 
hydrazine assay was some 15 times as sensitive.
D-aspartate oxidase activity in brain extracts. Table 8.1 
shows activities of D-aspartate oxidase in extracts from 
various brain regions of cat, hog, rat and sheep brain.
Fig, 8.1.
A. 2,4-Dinitrophenylhvdrazine assay. Linearity of oxo-acid 
formation from D-aspartate with respect to time and amount
of added protein using a 0-35% ammonium sulphate fraction of 
water extract cat brain acetone powder.
B. Ferricyanide assay. Linearity of ferricyanide reduction 
(and D-aspartate oxidation) with respect to amount of added 
protein using a 0-35% ammonium sulphate fraction of a water 
extract of cat kidney acetone powder. This assay was a 
continuous assay and initial velocities were determined from 
the slope of the spectrophotometer trace after the reaction 
was initiated by the addition of ferricyanide.
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Table 8.1. Enzymic activities in CNS and kidney tissue: 
2,4-dinitrophenyldrazine assay
Enzymic Activity (nmol of oxo- 
acid produced/min/mg protein)
Tissue
Ammonium 
Sulphate 
Fraction
D-Aspartate 
oxidase
D-Amino Acid 
oxidase
Cat forebrain* 0-50% 2.89
0-35% 7.31
35-100% < 0.09
Cat cerebellum 0-35% 3.44
35-100% 0.11
Cat spinal cord 0-35% 2.31
Hog brain 0-35% 1.08 1.61
35-50% 3.36 0.77
50-65% 0.53 0.02
65-100% <0.03 <0.01
Rat brain 0-35% 1.67
35-55% 0.40
Sheep brain stem 0-50% 2.89
Rabbit kidney** 0-35% 410
Cat kidney** 0-35% 270
35-100% 0
Cat kidney 0-35% 115
Each value represents a single determination of the initial rate 
of substrate oxidation, calculated from time-course experiments.
* Includes hemispheres, midbrain, thalamus and hypothalamus.
** These results are calculated from those obtained in the
ferricyanide assay, multiplied by a factor of 15 (see text) 
to give values which can be compared with results obtained 
in the 2,4-dinitrophenylhydrazine assay.
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These extracts were ammonium sulphate fractions of water 
extracts of acetone powders. Activities obtained from 
similar extracts of rabbit and cat kidney are given for 
comparison. It is apparent that the activity of brain 
D-aspartate oxidase is much lower than that of renal tissue, 
which accounts for the activity not being observed in CNS 
tissue using the ferricyanide assay.
Little reliance should be placed on the regional 
differences observed for the enzymic activity in cat CNS 
because of possible differential water extraction and ammonium 
sulphate precipitation of the enzyme from acetone powders. 
Using water extracts of different regions YUSKO & NIEMS 
(1973) found a relatively uniform distribution of the enzyme 
in hog brain, in contrast to D-amino acid oxidase activity, 
which is very much higher in cerebellum and pons-medulla 
than in other regions ( DeMARCHI & JOHNSTON, 1969) .
Ammonium sulphate fractionation of the hog brain 
acetone powder extract (Table 8.1) showed that the fraction 
with the highest specific activity for the oxidation of 
D-aspartate was different from the fraction with highest 
activity for the oxidation of D-alanine. This suggests that 
the two activities are due to two different enzymes, as 
shown conclusively for the kidney (STILL & SPERLING,
1950; STILL, BUELL, KNOX & GREEN, 1949; KREBS, 1935).
Substrate specificity of assayed activity. The apparent 
activity of D-aspartate oxidase from cat brain with various 
substrates is shown in Table 8.2. This experiment was 
performed in the presence of 2mM sodium benzoate, an inhibitor 
of D-amino acid oxidase, to prevent this enzyme contributing 
to oxo-acid oxidation products (KLEIN & KAMIN, 1941;
FRISELL, LOWE & HELLERMAN, 1956). Sodium benzrate was shown
Table 8.2. Substrate specificity of D-aspartate oxidase
from cat brain and kidney:
2,4-dinitrophenylhydrazine assay
Substrate Relative Activity
Brain Kidney
D-aspartate 100 100
N-Methyl-D-Aspartate 94 93
N-Ethyl-D-Aspartate 58 49
N-Propyl-D-Aspartate 31 39
N-Butyl-D-Aspartate 41 44
D-Glutamate 6 6
L-Glutamate
L-Aspartate
N-Methyl-L-Aspartate
D-Glutamine
L-Glutamine
D-Serine
L-Serine
D- Asparagine
L-Alanine
Glycine
GABA
No significant activity 
was observed with these 
compounds
The above compounds were tested at 20 mM final concentration 
in the standard assay system. Each value represents a single 
determination from 50 min incubations for the brain enzyme 
and duplicate determinations from 10 min incubations for the 
kidney enzyme. The extracts used were a 0-35% ammonium 
sulphate fraction of a water extract of cat cortex acetone 
powder and a 0-50% ammonium sulphate fraction of a water 
extract of cat kidney acetone powder. Sodium benzoate 
(2 mM) was present to inhibit D-amino acid oxidase activity 
in these extracts. For the brain extract, no significant 
activity was observed with D-alanine under these conditions. 
For the kidney extract, relative activity with D-alanine was 
16% (corrected for the different colour value of its oxo-acid 
product). Increasing the sodium benzoate to 10 mM reduced 
this to 6% without affecting the other values.
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to have no effect on the activity of D-aspartate oxidase 
using D-aspartate as substrate. All compounds were tested 
at 20 mM final concentration, and activities are expressed 
relative to D-aspartate as 100. Standard curves of colour 
development for the 2,4-dinitrophenylhydrazones of 
2-oxoglutarate and pyruvate, the products of oxidation of 
D-glutamate and D-alanine respectively, were determined 
(Fig.8.2) to check that observed lack of activity was not 
due to lack of colour development in the standard oxo-acid 
assay. It is apparent that D-aspartate and its N-substituted 
derivatives are the only amino acids tested which are 
oxidised to a significant extent by this enzyme, with 
activity generally decreasing with increasing size of the 
N-substituent. The cat kidney D-aspartate oxidase activity, 
assayed by the 2,4-dinitrophenylhydrazine method (Table 8.2), 
shows a very similar substrate specificity.
The substrate specificity of the cat kidney
D-aspartate oxidase assayed by the ferricyanide method is
given (Table 8.3). Benzoate is not needed to inhibit D-amino
acid oxidase in this assay because D-amino acid oxidase does
not use ferricyanide as an electron acceptor (DIXON & KLEPPE,
1965). The values obtained for the relative rates for
different substrates are not directly comparable with those
values obtained in the 2,4-dinitrophenylhydraz '.ne assay
(Table 8.2) due to differences in substrate concentration,
pH, acceptor and temperature in the two assays. The obvious
difference for D-glutamate can be explained by the fact
that the value of K for this substrate depends very muchm
on the acceptor used (DIXON & KENWORTHY, 1967). From the 
kinetic data of DIXON & KENWORTHY (1967) the rate of 
oxidation of D-glutamate (relative to D-aspartate as 100) 
using ferricyanide as acceptor can be calculated as 20.6 at
Fig, 8.2. Colour development of oxo-acids in the standard 
2,4-dinitrophenylhydrazine assay described in methods. 
Linearity of colour formation with amount of added oxo-acid 
is shown for oxaloacetate, 2-oxoglutarate and pyruvate, the 
oxidative deamination products of D-aspartate, D-glutamate 
and D-alanine respectively.
2-  0.4
0.3
OXO ACID (jumole)
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Table 8.3. Substrate specificity of D-aspartate 
oxidase from cat kidney: ferricyanide assay
Substrate Relative Activity
D-Aspartate 100
D-Glutamate 42
N-Methyl-D-Aspartate 38
N-Propyl-D-Aspartate 6
D-Serine 2
D-Alanine 2
L-Alanine ) 
L-Serine j 
Glycine ) 
GABA | 
L-Glutamine ) 
D-Glutamine j 
D-Asparagine ) 
L-Aspartate j 
L-Glutamate )
No significant activity 
was observed with these 
compounds
The above compounds were 
ferricyanide assay. The
tested at 6.7 mM in the standard 
enzyme was a 0-35% ammonium
sulphate fraction of an acetone powder extract of cat 
kidney. Each value represents the mean of duplicate 
determinations of the initial velocity of ferricyanide 
reduction.
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6.67 mM substrates and 40.5 at 20 mM substrates, whereas the
rate with 0  ^ as acceptor is 8.4 at 6.67 mM substrate and
11.2 at 20 mM substrates, i.e. there is much less oxidation
of D-glutamate with O2 as acceptor than with ferricyanide as
acceptor. Using a cat kidney extract, activity was measured
by the ferricyanide assay at 6 concentrations of D-aspartate
in the range of 6.7-50 mM, and for 6 concentrations of
D-glutamate in the range 8.3-83 mM. At pH 7.6 and 30°C,
approximate K and V values for D-aspartate were 35 mM m max
and 0.41 0 .D. ^ g/n^n/mg respectively, whereas for D-glutamate
the corresponding values were 231 mM and 0.67 0.D.42Q/min/mg.
Values for D-glutamate are very approximate because the range
of substrate concentrations used was well below the actual
K , but results are in general, comparable with those of m
DIXON & KENWORTHY (1967) in that with ferricyanide as 
acceptor the for D-glutamate is much higher than for 
D-aspartate and under saturating conditions for both 
substrates, D-glutamate is oxidized faster than D-aspartate.
Cofactor requirement. D-aspartate oxidase from cat cortex 
and cat cerebellum exhibited less than 20% of maximal 
activity when FAD was not included in the assay. Addition 
of FMN did not restore activity (Table 8.4).
Inhibitors of D-aspartate oxidase activity. Sodium benzoate, 
a relatively potent inhibitor of D-amino acid oxidase 
activity from extracts of human cerebellum and hog kidney 
(NIEMS, ZIEVERINK 6c SMILACK, 1966) was without effect on 
cat brain D-aspartate oxidase activity (Table 8.4). Sodium 
barbitone at 10 mM final concentration also failed to inhibit 
D-aspartate oxidase activity; GOLDSTEIN (1966) reported 
that sodium pentobarbitone was a weak competitive inhibitor 
of sheep cerebellum D-amino acid oxidase activity. D-tartrate 
(2mM) (Fig.8.3) competitively inhibited sheep brain-stem
Table 8.4. Inhibitors and cofactor requirements of 
cat brain D-aspartate oxidase:
2, 4-dinitrophenylhydrazine assay
Oxidase Activity
Assay Conditions Cortex Cerebellum
Complete 100 100
-FAD 11 21
-FAD, +FMN (10 ]iM) 24 30
-FAD, +FMN (25 yM) 26 -
Sodium Benzoate (1 mM) 99 95
Sodium D-Malate (10 mM) 79 73
Sodium Barbitone (10 mM) 98 -
Activities are expressed as percentage of the activity 
observed with the complete assay system. Each value 
represents the mean of two determinations from 45 min 
incubations. The extracts used were 0-35% ammonium 
sulphate fractions of water extracts of cat brain acetone 
powders.
Fig. 8.3. Lineweaver-Burk plots of the activity of D-aspartate 
oxidase with concentrations of D-aspartate in the range 
4-40 mM, in the presence and absence of 2 mM D-tartrate.
Each point represents a single determination and results 
were fitted to the equation for linear competitive inhibition 
by the method of CLELAND (1963) to yield mean values - S.E.M. 
of the apparent kinetic parameters. The extract was a 0-50% 
ammonium sulphate fraction of a water extract of sheep brain 
stem acetone powder. Units of v are optical density change 
at 416 nm/45 min/0.2 ml of extract. The K for D-aspartate 
was calculated as 3.8 - 0.2 mM and V asm2.77 ^ 0.07 
nmol/min/mg protein. for D-tar?rate was 2.43 - 0.31 mM.
CO
d
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D-aspartate oxidase activity when tested against varying 
concentrations of D-aspartate in the standard, 2,4-dinitro- 
phenylhydrazine assay. D-tartrate, malonate and DL-malate, 
when tested at 20 mM final concentration in the standard 
assay against the hog brain enzyme gave inhibitions in the 
range 66-83%. The kidney enzyme was quite strongly 
inhibited by dicarboxylic acids (DIXON & KENWORTHY, 1967) 
as was the hog brain enzyme by sodium mesotartrate (YUSKO 
& NIEMS, 1973) .
Kinetics of D-aspartate oxidase activity. Using ammonium 
sulphate fractions of brain and kidney extracts, initial 
velocity of oxo-acid formation was measured for a range 
of concentrations of D-aspartate from 2 - 40 mM (Table 8.5,
Fig. 8.4). When assayed under identical conditions, the 
K^'s for D-aspartate are very similar for the kidney and 
brain enzymic activities. The V parameters, although 
not directly comparable because of possible differential 
water extraction and to the fact that different ammonium 
sulphate cuts were used, show that kidney has much more 
maximum activity than brain, although the affinity for 
D-aspartate, as evidenced by the K^ value, is similar.
This is consistent with the same or at least a very similar 
enzyme being present in brain and kidney. An attempt was 
made to measure velocities for a range of D-glutamate 
concentrations from 10 to 100 mM, but activities were too 
low to give accurately measurable colour. At 20 mM 
D-glutamate both the hog brain and cat kidney enzyme had 
approximately 6% of the activity observed with 20 mM D-aspartate, 
while at near saturating concentrations of both substrates 
the activity with D-glutamate was of the order of 10% 
of the activity with D-aspartate.
Table 8.5. Apparent kinetic constants of D-aspartate 
oxidase from brain and kidney acetone powder 
extracts: 2,4-dinitrophenylhydrazine assay
Tissue
Ammonium
Sulphate
Fraction
Km (mM)
V (nmol/min/mg max / • xprotein)
Sheep brain stem 0-50% 3.8 + 0.2 2.77 -0.07
Cat brain 0-50% 5.8 + 0.2 3.74 -0.05
Hog brain 35-50% 3.7 + 0.1 3.18 - 0.04
Cat kidney 0-50% 6.5 0.3 124.0 -  1.9
Initial velocities of D-aspartate oxidation by the acetone 
powder extracts were determined for a range of D-aspartate 
concentrations from 2-40 mM. The results were analysed 
by the method of CLELAND (1963) to yield mean values *
S.E.M. of the apparent kinetic parameters. Vnu va-lues 32:0 
not directly comparable due to possible differential water 
extraction of acetone powders and different ammonium sulphate 
cuts.
Fig. 8.4. Lineweaver-Burk plots of the activity of D-aspartate 
oxidase with concentrations of D-aspartate in the range 
2-40 mM. Each point represents the mean of duplicate 
determinations and results were analysed by the method of 
CLELAND (1963) to yield mean values - S.E.M. of the apparent 
kinetic parameters (see Table 8.5).
A: The extract was a 35-50% ammonium sulphate fraction
of a water extract of hog brain acetone powder.
B: The extract was a 0-50% ammonium sulphate fraction
of a water extract of cat kidney acetone powder.
BRAIN
KIDNEY
1  0.02
- 0.3 - 0.2 - 0.1 0.0 0.1 0.2 0.3 0.4 0.5
1/S
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4. DISCUSSION
An enzymic activity capable of oxidizing D-aspartate 
has been demonstrated in water extracts of acetone powders 
prepared from cat forebrain, cerebellum and spinal cord, rat 
brain, hog brain and sheep brain stem. Activities obtained 
for brain D-aspartate oxidase activity were in the range 
1-7 nmole/min/mg protein for the partially purified extracts 
used, a figure which is reasonably similar to the activities 
observed by YUSKO & NIEMS (1973) who obtained values in 
the range 11-200 nmole/min/g wet weight of tissue for water 
homogenates. Like D-amino acid oxidase, the D-aspartate 
oxidase activity of brain is much less than that in kidney.
In agreement with YUSKO & NIEMS (1973) this enzyme appears to 
be broadly distributed within the CNS and appears to be a 
separate enzyme from D-amino acid oxidase.
The results of studies involving the specificity 
of the enzyme towards substrates, inhibitors and activating 
cofactors suggest that the brain enzyme is the same, or at 
least very similar to the D-aspartate oxidase (D-aspartate: 
oxygen oxidoreductase (deaminating), EC 1.4.3.1) of kidney 
which was first studied by STILL, BUELL, KNOX & GREEN (1949). 
Crude extracts (ammonium sulphate fractions of water extracts 
of acetone powders) displayed little activity without added 
FAD; FMN could not replace FAD. Those amino acids 
susceptible to oxidation by D-amino acid oxidase were not 
oxidised by the D-aspartate oxidase. As previously 
observed for the kidney D-aspartate oxidase activity, 
dicarboxylic acids competitively inhibited this enzymic 
activity in brain extracts, while sodium benzoate and sodium 
barbitone, inhibitors of D-amino acid oxidase, were without 
effect. With oxygen as electron acceptor, the enzyme 
oxidized D-aspartate much more rapidly than D-glutamate,
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and displayed quite high activities with N-substituted 
derivatives of D-aspartate as substrates.
The enzymic activity observed with N-substituted 
derivatives of D-aspartate is consistent with the mechanism 
of enzyme-substrate interaction proposed by DIXON & KENWORTHY 
(1967). The active centre of D-aspartate oxidase is 
postulated to contain groups which combine with the two 
carboxyl groups of the substrate (or dicarboxylic acid 
inhibitor) , giving two links which hold the substrate molecule 
to the enzyme. When the D-dicarboxylic amino acid substrate 
is in position on the active site the amino group is directed 
away from the enzyme surface, whereas in the L-configuration, 
the inwardly directed amino group is sufficient to overcome 
the attraction of the two carboxyl groups for the enzyme.
It appears that a substituent on an amino group in the 
D-configuration does not drastically affect enzyme substrate 
binding and oxidative deamination. Further, the competitive 
inhibition of the enzyme by the dicarboxylic acids D-tartrate, 
malonate and malate is consistent with the ability of these 
dicarboxylic acids to compete with D-aspartate for the active 
centre.
The regional distribution of the D-aspartate 
oxidase activity within the CNS differed from that of the 
D-amino acid oxidase. An attempt to measure the subcellular 
distribution of the enzyme in the rat CNS was unsuccessful 
because of the low activity of the enzyme. Measurements of 
subcellular distribution in kidney may prove easier, because 
of the greater activity in this organ. The cellular 
distribution of the enzyme in brain and kidney tissue also 
remains unknown; in fact, the function of enzymes in these 
tissues which oxidise the D-isomers of many amino acids 
remains enigmatic.
D-ASPARTATE IN THE CENTRAL NERVOUS SYSTEM:
PRESENCE OR ABSENCE?
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1. INTRODUCTION
In the previous two chapters a number of observations 
have been made about the D-isomers of the dicarboxylic 
acids, aspartate and glutamate.
1. D-aspartate and D-glutamate excite cat spinal 
neurons when administered microelectrophoretically, 
being only slightly less potent than the 
corresponding L-isomers (CURTIS & WATKINS, 1960) .32. D-aspartate is a good inhibitor of [ H]L-aspartate3and [ H]L-glutamate high affinity uptake into cat
spinal cord slices (BALCAR & JOHNSTON, 1973) and 
3of [ HiL-glutamate high affinity uptake into 
rat cerebral cortex slices (BALCAR & JOHNSTON,
1972a, 1972b). In fact, D-aspartate is a more3powerful inhibitor of [ H)L-glutamate uptake 
than either D- or L-glutamate.
3. In rat brain, a similar high affinity uptake 
system to that described for L-glutamate (BALCAR
& JOHNSTON, 1972a) exists for D-aspartate (Section 
VII). Much of this uptake appears to take place 
into osmotically-sensitive particles which band 
in the same position in sucrose density gradients 
as those particles which accumulate L-aspartate. 
D-aspartate is a more potent inhibitor of3[ H]L-aspartate uptake than is the L-isomer.
4. D-aspartate oxidase, an enzyme specific for 
the oxidation of D-dicarboxylic acids and more 
active on D-aspartate than D-glutamate (at least 
under in vitro conditions), appears to be broadly
distributed within the mammalian CNS (Section 
VIII).
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Furthermore, it was noted that there is a discrepancy 
in two studies reporting the level of aspartate in six regions 
of the feline spinal cord. Using the ninhydrin colour reaction, 
JOHNSTON (1968) obtained values which, in five of the six 
regions, were between 44% and 96% higher than those obtained 
using a fluorometric enzymic method specific for the L-isomer 
(GRAHAM, SHANK, WERMAN & APRISON, 1967). A comparison of other 
amino acids measured, including glutamate, glutamine and glycine 
showed either no significant difference or ninhydrin values 
slightly lower than enyzmic method values. In view of the fore­
going observations, an investigation was undertaken to see 
whether the CNS contained any D-aspartate.
For many years it was believed that only L-amino 
acids occurred in nature and thus the D-isomers were categorized 
as 'unnatural isomers'. The occurrence of D-amino acids 
in a variety of microorganisms in both the free state and in 
peptide linkage has now been demonstrated (see MEISTER, 1965).
Of a number of invertebrate species shown to contain D-amino 
acids, the earthworm Lumbricus terrestris has been shown to 
contain free D-serine, the milkweed bug Oncopeltus fasciatus 
free D-alanine, while the luciferin of fireflies contains a 
D-cysteine moiety (MEISTER, 1965). There is no conclusive 
evidence, however, for the occurrence of D-amino acids in 
mammals. It has been claimed that tumour proteins contained 
D-amino acids (KOGL & ERXLEBEN, 1939), but these results have 
not been verified. KUHN (1958) isolated small amounts of 
D-leucine from horse hair protein hydrolysates; however this was 
probably due to racemization occurring during hydrolysis 
(CORRIGAN, 1969).
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A large amount of work has been devoted to the 
resolution and analysis of the optical isomers of amino 
acids. These methods have been reviewed by GREENSTEIN (1961). 
His extensive review covered selective crystallization of 
free amino acids or salts of amino acids and derivatives, 
biological methods utilizing optically-specific enzymes for 
free or appropriately substituted amino acids and paper or 
column chromatographic approaches. Recently, much work 
has developed methods suitable for automated column 
chromatography, either by synthesis of suitable diastereo- 
isomeric derivatives of amino acids, or by synthesis of 
optically-active stationary phases. L-leucyl dipeptides 
of 21 racemic amino acids have been synthesized and the 
L-L and L-D dipeptides clearly separated by ion exchange 
chromatography (MANNING & MOORE, 1968). Gas-liquid 
chromatography has been used to successfully separate 
diastereoisomeric derivatives of seven racemic amino acids 
(POLLOCH & KAWAUCHI, 1968). The free amino acids, isoleucine, 
proline and allothreonine have been separated into isomers 
on an asymmetric complex-forming polystyrene resin (ROGOZKIN, 
DAVANKOV, YAMSKOV & KABANOV, 1972).
The first approach made in determining if D-aspartate
was present in CNS extracts was to use specific enzymes.
An experiment, using the standard ferricyanide assay for
D-aspartate oxidase (Section VIII), was performed to see
whether an acid-soluble CNS extract could support reduction
of ferricyanide in the presence of kidney D-aspartate
oxidase. However, the K of the kidney extract oxidasem
activity was too high for this approach to be sufficiently 
sensitive.
By using enzymes specific for one isomer it was 
thought that a possible approach would be to remove L-aspartate
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from a brain extract by exhaustive digestion with the
enzyme, then analyse the reaction supernatant by an amino
acid analyser to see if the ninhydrin-positive aspartate
peak was completely removed. To this end the enzymes
L-aspartate (5-decarboxylase (L-aspartate 4-carboxy-lyase)
and L-amino acid oxidase were used. L-aspartate ß-decarboxylase
has been used previously to prepare [^ c]D-aspartate from 
14[ c ] DL-aspartate (MARGOLIS & LAJTHA, 1968; see Section 
VII.2), while procedures describing the use of L-amino acid 
oxidase for small scale preparation of D-isomers of a number 
of amino acids have been well documented (PARIKH, GREENSTEIN, 
WINITZ & BIRNBAUM, 1958).
Because of difficulties experienced with this 
approach, L-leucyl dipeptides of amino acids in CNS extracts 
were synthesised and subjected to column chromatography 
on an amino acid analyser. This involved synthesis of 
L-leucine-N-carboxyanhydride and its subsequent reaction 
with CNS amino acid extracts under carefully controlled 
conditions (MANNING & MOORE, 1968). The use of thin-layer 
chromatography for separation of diastereoisomeric peptides 
was investigated.
2. METHODS AND MATERIALS
Incubation of a synthetic amino acid mixture and cat brain 
and spinal cord extracts with a Clostridium welchii extract. 
Reaction mixtures, in a final volume of 2.6 ml, consisted 
of 0.5 ml of 0.2 M sodium acetate buffer, pH 4.9, 0.6 ml 
of 100 mM sodium pyruvate in sodium acetate buffer, 0.05 ml of3[ H]L-aspartate (0.1 pCi), 75 mg of Cl.welchii acetone 
powder (containing L-aspartate ß-decarboxylase) and 1.4 ml 
of one of the following amino acid extracts: (1) a synthetic
mixture of 14 naturally-occurring amino acids (0.93 pmol 
of each); (2) neutralized perchloric acid extract of
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cat cortex; (3) neutralized perchloric extract of cat 
cord. Reaction mixtures, contained in Kontex flasks 
(25 ml), were stoppered and incubated for 10^/2 h at 37°C 
in a shaking water bath. Enzyme blanks (complete reaction 
mix minus enzyme extract) for each extract and a substrate 
blank (to check on amino acid contamination from the acetone3powder) were run concurrently. [ H]L-aspartic acid was 
included to follow the extent of decarboxylation to L-alanine. 
Pyruvate was added to reaction mixtures as the presence of 
a-oxo-acids has been shown to stimulate L-aspartate ß- 
decarboxylase (MEISTER, SOBER & TICE, 1951).
Reactions were stopped by the addition of 6.1 ml 
of absolute ethanol (to give a final ethanol concentration 
of 70%) and centrifuged to remove protein. Samples were 
evaporated to dryness in vacuo (temperature < 37°C) and 
resuspended in 4 ml of 0.02 N hydrochloric acid. To check 
on the extent of reaction 1 ml of each sample was brought 
to pH 7-8 and loaded onto small columns of Dowex 1 x 8  
(acetate form; 200-400 mesh; 5 ml of resin contained in 
glass columns of 7 mm I.D.). Columns were eluted with water 
(40 ml) and 0.02 N acetic acid (10 ml), then with 2N acetic 
acid (40 ml). L-a-alanine came through in the water wash 
while L-aspartate was eluted with the 2 N acetic acid.
The remainder of the samples from the enzymic digestion were 
used for amino acid analysis.
Extraction of L-aspartate decarboxylase activity from
Cl. welchii acetone powder. Previous work on the preparation
14of radioactive D-aspartate from [ c]DL-aspartate (Section 
VII.2) showed that brief stirring of the acetone powder with 
0.2 M sodium acetate buffer, pH 4.9 failed to extract 
L-aspartate ß-decarboxylase activity. For this reason 
the acetone powder was weighed out and added directly to the 
incubation mixtures. To eliminate the amino acid contamination
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present in these crude powders, attempts were made to 
purify the decarboxylase activity. 350 mg of acetone 
powder was suspended in 7 ml of 0.17 M sodium chloride and 
dialysed against 0.17 M sodium chloride and 1 mM EDTA in 
the cold (4°C). Dialysis with stirring was continued against 
several changes of the salt solution for approximately 20 h, 
then against sodium acetate buffer, pH 4.9, for a further 
4 h. The suspension was then centrifuged and the supernatant 
incubated with a synthetic amino acid mixture and with 
extracts of cat cortex and cord for 21^/2 h. Reaction 
mixtures were the same as described above, with the exception 
that the amount of pyruvate added per incubation flask was 
reduced from 60 ymol to 5 ymol. Reactions were stopped and 
processed as described above.
Incubation of a synthetic amino acid mixture with L-amino 
acid oxidase from rattlesnake (Crotalus adamanteus) venom.
The procedure used was a modification of the method described 
by PARIKH, GREENSTEIN, WINITZ & BIRNBAUM (1958). Crude 
Crotalus adamanteus venom extract (Sigma Type I) was dissolved 
in 0.2 M potassium phosphate buffer, pH 7.2 and dialysed 
for 7-8 h at 4°C in water then potassium phosphate buffer. 
Catalase was also dialysed under the same conditions.
Extensive dialysis was carried out to remove free amino 
acids contained in these extracts. To each of three Kontes 
flasks (25 ml), was added 1.5 ml of 0.2 M potassium phosphate 
buffer, pH 7.2 and 0.1 ml of catalase (1 mg/ml). To one 
flask was added 1.0 ml of L-amino acid oxidase (5 mg/ml) 
and 2 ml of a synthetic mixture containing 2 pmol each 
of 18 amino acids (see Table 9.2). To the second was 
added 2 ml of the amino acid mixture and 1.0 ml of buffer 
(i.e. no L-amino acid oxidase), while the third received 
1.0 ml of L-amino acid oxidase extract and 2 ml of water
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(i.e. no amino acids). Reaction bottles were gassed with 
oxygen, stoppered and incubated at 37°C in a shaking water 
bath for 20 h. Reactions were stopped with 10.4 ml of 
absolute ethanol (to give a final concentration of 70% 
ethanol) and left for 1 h. Protein was sedimented by 
centrifugation (12,000 x g for 10 min), the supernatants 
concentrated to dryness in vacuo and resuspended in 5 ml 
of water.
2.5 ml aliquots were acidified and loaded onto 
small columns of Dowex 50W x 4 (200-400 mesh; 11 mm I.D.,
2.5 cm high) (LAZARUS, 1973). Columns were washed with 
45 ml of 0.01 N hydrochloric acid, 5 ml of water and eluted 
with approximately 30 ml of 2N ammonia. These eluates 
were evaporated to dryness several times to remove ammonia, 
resuspended in 2 ml of 0.01 N hydrochloric acid and used 
for amino acid analysis.
Synthesis of L-leucine-N-carboxyanhydride. L-leucine-N- 
carboxyanhydride (L-4-isobutyloxazolidine 2:5-dione) was 
prepared by a modification of a published procedure (COLEMAN, 
1950). L-leucine (11.6 g) was suspended in dry dioxan 
(200 ml; purified by filtration through 100 g aluminium 
oxide and freshly distilled from sodium shavings) at 40°C.
With vigorous stirring, a solution of phosgene (12.5% in 
toluene, 100 ml) was added dropwise over a 2 h period.
Then a stream of air was passed rapidly through the reaction 
mixture (kept at 40°C) for 16 h to remove excess phosgene.
All exhaust gases from the reaction mixture were passed 
through five bubblers of 20% sodium hydroxide. The mixture 
was filtered and the filtrate concentrated in vacuo. The 
product crystallized almost immediately and was recrystallized 
from ether-petroleum ether to give small white flakes.
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The reaction yielded 5.3 g of the product which was identified 
as being the required material on the basis of its solubility 
in petroleum ether, insolubility in ether, its reaction 
with water to give L-leucine and its ability to react with 
amino acids (as evidenced by thin-layer chromatography).
Preparation of acidic amino acid extracts of CNS tissue. Rat 
cord, rat brain, cat cord and cat brain tissue samples were 
homogenized with 10 volumes of 0.6 N perchloric acid. After 
standing 30 min on ice, the extracts were centrifuged 
(17,000 x g for 10 min), supernatants decanted and the 
precipitates washed with 10 ml of 0.6 N perchloric acid. 
Following recentrifugation, supernatants and washings were 
combined and neutralized with potassium hydroxide. Insoluble 
potassium perchlorate was removed by centrifugation, the 
supernatants evaporated to dryness in vacuo (temperature < 37°C), 
and resuspended in 6 ml of water. After a recentrifugation 
to remove remaining potassium perchlorate, 3 ml of each 
sample (pH 7-8) was loaded onto Dowex 1 x 8  columns (acetate 
form; 200-400 mesh; 5 mm I.D., 3.5 ml of resin) and washed 
with 37 ml of water. Acidic amino acids were eluted with 
30 ml of 2 N acetic acid. The acid eluates were evaporated 
to dryness in vacuo, suspended in a small volume of water 
and re-evaporated to dryness, then suspended in 4 ml of 
sodium borate buffer (pH 10.2 at 25°C). 2 ml of these
samples were used for derivitization, while the rest was 
used for thin-layer chromatography, to check the presence 
of acidic amino acids in the CNS extracts.
Reaction of L-leucine-N-carboxyanhydride with optical isomers 
of amino acids and with CNS tissue amino acid extracts.
The procedure used was that described by MANNING & MOORE 
(1968). 2 Ml of 10 mM L-aspartate, D-aspartate, L-glutamate
and D-glutamate in borate buffer (13.9 g of boric acid to
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480 ml with freshly boiled distilled water, pH adjusted to 
10.2 at room temperature with 5 N sodium hydroxide and made 
up to 500 ml) were added to separate graduated glass 
centrifuge tubes. Tubes containing 2 ml of extract of 
cat cortex, cat cord, rat brain and rat cord in borate 
buffer were also prepared. Amounts of L-leucine-N- 
carboxyanydride, chosen to give approximately 5-fold molar 
excess over amino acid (assuming 20 ymol/g wet weight of 
acidic amino acids in tissue extracts) were weighed out in 
small glass vials. The coupling reactions were performed 
in the cold room (4°C) and tubes were cooled on ice before 
derivitization. The tubes were vigorously agitated on a 
vortex mixer at maximum setting and the L-leucine-N- 
carboxyanhydride quickly added to the swirling solution.
The agitation was continued for two minutes, briefly removing 
the tubes from the mixer approximately every 30 sec to ensure 
complete solution of the N-carboxyanhydride. The reaction 
was terminated by adding 0.8 ml of 1 N hydrochloric acid 
to bring the pH to 1-3. At this stage the peptide solution 
was filtered to remove slight cloudiness and stored in 
the freezer until chromatographic analysis was carried out.
Thin-layer chromatography of peptide solutions. Derivatized 
solutions were spotted and run on the following plates: (1) pre
coated silica-gel plates (Merck), 5 x 20 or 20 x 20 cm plates, 
0.25 mm thick; (2) microcrystalline cellulose (Avicel).
100 gof Avicel were suspended in 430 ml of water with a 
Waring blender and spread on 20 x 20 cm glass plates,
0.25 mm thick. Plates were allowed to dry for 24 h before 
use.
The following solvent systems were used:
(a) absolute ethanol:water (60:40); (b) n-propanol:25%
ammonia (67:33); (c) butanol:acetic acid:water (4:1:1).
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L-leucine, L-aspartate and L-glutamate were run with samples 
of the dipeptides. Plates were developed with ninhydrin 
spray (0.2% w/v in acetone).
Column chromatography of peptide solutions. Dipeptide 
derivatives were separated by Mr L.B. James on a Technicon 
Auto-Analyzer modified for amino acid analysis (JAMES, 1972). 
A 23 cm glass column (0.9 cm I.D.) containing Beckman 
PA-35 resin (height of bed = 14 cm) was used. Eluting buffer 
was 0.2 M sodium citrate, pH 3.25.
3Chemicals. [u- HjL-aspartic acid was purchased from New
England Nuclear, Boston. L-glutamate decarboxylase (Type 
III, crude acetone powder from Clostridium welchii) and 
L-amino acid oxidase (Type I, crude Crotalus adamanteus 
rattlesnake venom extract) were purchased from Sigma.
Catalase was from Nutritional Biochemicals. Other chemicals 
were obtained from the following sources: L-leucine, GABA
and L-methionine (Calbiochem); L-serine, 3-alanine and 
DL-threonine (Fluka); aspartic acid, L-u-alanine, L-proline 
(Sigma); glutamic acid, taurine, L-valine and Phosgene 
(B.D.H.); asparagine (Cyclo); glycine (Mann); 
L-phenylalanine (Koch-Light) and L-lysine (Merck).
3, RESULTS
Incubation of cat brain and spinal cord extracts with Cl. 
welchii acetone powder (containing L-aspartate r- 
decarboxylase). Incubation of amino acids with Cl. welchii 
acetone powder resulted in almost complete destruction of
3[ H]L-aspartate (Table 9.1). However, amino acid analysis 
of the substrate blank incubation (complete incubation mix 
minus added amino acids) revealed the presence of extensive 
amino acid contamination from the acetone powder. The 
chromatogram of acidic and neutral amino acid analysis
Table 9.1. Incubation of amino acid mixtures with crude 
acetone powder from Clostridium welchii
Acetone CPM in 2 N % of CPM left
Sample powder acetic acid in [^H]L-asp.
wash
Synthetic amino
acid mix (1) + 261 2.5
— 8805
Synthetic amino
acid mix (2) + 1583
17.7
- 8759
Cat cortex extract + 401
- 8489 4.2
Cat cord extract + 425
- 9096 4.2
Substrate 'blank' + 3.9
A synthetic amino acid mixture, or cat CNS extracts were 
incubated with acetone powder from Clostidium welchii 
(containing L-aspartate ß-decarboxylase activity) under 
conditions described in 'Methods and Materials' (Section VII.2). 
[2- h^ ]L-aspartate was added to follow the breakdown of aspartic 
acid. ■*+' and '-' indicate incubation of the amino acids in 
the presence or absence of the acetone powder, respectively. 
Reaction supernatants were applied to columns of Dowex 1 x 8  
(acetate form; 200-400 mesh). Radioactive L-a-alanine, the 
breakdown product of aspartate decarboxylation, came through 
in the water wash and substrate L-aspartate in the 2 N acetic 
acid wash. The Substrate 'blank' had [%] L-aspartate but no 
other added amino acids.
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showed 22 major and eight to nine minor ninhydrin positive 
peaks. In the amino acid digestion experiments the L-alanine 
peaks were greatly increased, while glutamate and aspartate 
peaks were reduced in comparison to enzyme-blank controls. 
However, interpretation of analyses was rendered virtually 
impossible by exogenous peaks from the Cl. welchii extract. 
Furthermore, the presence of bacterial amino acids precluded 
any conclusions as to the presence or absence of D-aspartate. 
Therefore an attempt was made to extract the L-aspartate 3 - 
decarboxylase activity from the acetone powder and to dialyse 
away amino acids and other low-molecular weight components.
Attempts to extract activity into buffer by 
extensive dialysis were unsuccessful. The supernatant from 
an acetone powder suspension which was dialysed in buffer 
for 24 h with stirring was inactive in decarboxylating3[ H]L-aspartate. Failure to observe activity could have 
been due to the following factors: (1) loss of pyridoxal
5'-phosphate from the enzyme during dialysis, with resultant 
lack of activity of the apoenzyme in the incubation mixture 
which did not include pyridoxal 5'-phosphate; (2) loss of 
activity over the extended dialysis period; (3) failure of 
the sodium acetate buffer to extract the activity from the 
acetone powder.
It was evident from the work of NISHIMURA, MANNING 
& MEISTER (1962) that lack of activity was not due to the 
first point. Working on purified L-aspartate ß-decarboxylase 
from lyophilized Cl. welchii, all attempts to remove enzyme 
bound vitamin by extensive dialysis or enzyme precipitation 
were unsuccessful. The only way to reduce the concentration 
of the prosthetic group was by U.V. irradiation. Added 
pyridoxal phosphate stimulates the enzyme, and it appears 
that this can act both as a prosthetic group and as a less
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tightly bound cofactor. Furthermore, added a- -xo acids 
produce a stimulation equivalent to that observed by 
pyridoxal phosphate. Only a slight further stimulation 
occurs when both are added. The second possibility, i.e. 
inactivation over the long dialysis period, cannot be 
discounted, although in the purification procedure used 
by NISHIMURA, MANNING & MEISTER (1962) an 18 h dialysis was 
used. If the third possibility was the case, then the 
aspartate 3-decarboxylase activity would have been removed 
from the dialysed acetone powder suspension by centrifugation; 
this would explain why the supernatant used lacked activity. 
Interestingly, several studies (EPPS, 1945; GALE, 1945;
GALE, 1957) have shown that of a number of bacterial 
decarboxylase enzymes, the glutamate decarboxylase was often 
inactivated by preparation of acetone powders. The stability 
of aspartate 3-decarboxylase to acetone powder preparation 
has not been reported, but all purifications of this enzyme 
from bacteria have commenced with either freeze-dried 
material (NISHIMURA, MANNING & MEISTER, 1962; MEISTER,
SOBER & TICE, 1951) or sonically-disrupted frozen cell paste 
(TATE, NOVOGRODSKY, SODA, MILES & MEISTER, 1970; MILES & 
SPARROW, 1970).
Incubation of a synthetic amino acid mixture with L-amino 
acid oxidase from rattlesnake (Crotalus adamanteus) venom. 
PARIKH, GREENSTEIN, WINITZ & BIRNBAUM (1958) reported amounts 
of crude Crotalus adamanteus venom suitable for preparing 
optically-pure D-amino acids from racemic mixtures. Using 
an excess amount of venom, oxidation of dicarboxylic acids, 
L-aspartate and L-glutamate was negligible (Table 9.2). 
Results of GREENSTEIN, BIRNBAUM & OTEY (1953) on the rate of 
oxidation of various amino acids by rattlesnake venom are 
given for comparison. A report (KEARNEY & SINGER, 1949)
Table 9.2. Oxidation of amino acids by L-amino acid 
oxidase from rattlesnake (Crotalus adamanteus) venom
Amino acid Percent amino acid oxidized
Oxidation by ^
L-amino acid oxidase
Methionine 99.2 243
Leucine 99.0 225
Phenylalanine 98.7 185
Valine 99.4 9
Cystine 82.5 63
Alanine 41.1 0.9
Lysine n.d. 0.4
Glutamic acid 6.8 0.2
Proline 1.2 0.0
Aspartic acid 0.0 0.1
Threonine 0.0 0.0
j3-alanine 0.0 n.d.
Glycine 0.0 n.d.
Serine* * 32.0 0.0
Glutamine* — n.d.
Values are expressed as percent amino acid oxidized during 
20 h incubation of 2 nmoles each of 18 amino acids with 
5 mg of L-amino acid oxidase from Crotalus adamanteus venom.
There was no contribution to amino acids from the enzyme extract.
* Serine and glutamine peaks not separated on the amino acid 
analyser.
** Data from GREENSTEIN, BIRNBAUM & OTEY (1953). Rates are 
in terms of nmoles of oxygen consumed/hour/mg of protein, 
n.d. = not determined.
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which showed L-amino acid oxidase to be largely inhibited 
by inorganic phosphate was subsequently found. Thus the 
phosphate buffer used here was a poor choice; the tris-HCl 
buffer of PARIKEI et al. (1958) was not used because it was
thought that the tris carried through in the column desalting 
procedure would interfere with the amino acid analyses.
The use of another buffer and the elimination of inorganic 
phosphate may allow this approach to be utilized successfully 
for determining the presence or absence of D-isomers of amino 
acids. Using tris buffer under the same incubation conditions, 
acidic amino acids were separated from a reaction supernatant 
and analysed. However, there appeared to be little oxidation 
of glutamate and aspartate in the 20 h incubation period.
Separation of diastereoisomeric dipeptide derivatives of 
amino acids in cat and rat CNS extracts. Thin-layer 
chromatography of CNS extracts (before dipeptide derivitization) 
in butanol:acetic acid:water (4:1:1) showed the presence of 
major spots of glutamate and aspartate, and several other 
spots which were not directly identified. Chromatography 
of derivatized samples on silica-gel plates in outanol:acetic 
acidiwater resulted in good separation of diastereoisomers, 
with clear sharp spots and reproducible Rf's (Fig. 9.1).
None of the other solvents was as effective, while 
chromatography on Avicel plates resulted in smearing and 
diffuse overlapping spots. From TLC analysis it was apparent 
that neither in cat or rat tissue samples was there a spot 
corresponding to authentic L-leucyl-D-aspartate. In all 
samples spots corresponding to the L-leucyl-L-aspartate 
and L-leucyl-L-glutamate were present, while in cat cortex and 
cord extracts spots running in an equivalent position to 
standard L-leucyl-D-glutamate were apparent. To check 
whether this was the L-leucyl-dipeptide of D-glutamate,
Fig. 9.1. Thin layer chromatography of amino acid samples, 
before and after derivitization with L-leucine N-carboxyanhydride. 
20 x 20 cm precoated silica gel plates (Merck), layer thickness 
0.25 mm, were used. The solvent system was butanol:acetic 
acidiwater (4:1:1). Plates were run for 3.5 h at room 
temperature and spots developed with ninhydrin spray (0.2% w/v 
in acetone).
A. Aspartate, glutamate and rat and cat CNS extracts before 
derivitization.
B. D- and L-aspartate, D- and L-glutamate and rat and 
cat CNS extracts after derivitization with L-leucine 
N-carboxyanhydride. Free aspartate, glutamate and L-leucine 
were also run on the same plate.
The following abbreviations are used:
LLG = L-leucyl-L-glutamate 
LDG = L-leucyl-D-glutamate 
LLA - L-leucyl-L-aspartate 
LDA = L-leucyl-D-aspartate
C.CX = cat cerebral cortex extract 
C.CD = cat spinal cord extract 
R.CX = rat cerebral cortex extract 
R.CD = rat spinal cord extract 
STDS = derivatized standards
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samples were run on an amino acid analyser. Spots travelling 
ahead of L-leucine on TLC were presumed to be tri- and 
higher peptides, although not positively identified.
Column chromatography of derivatized standards 
on the amino acid analyser resulted in the following order 
of elution (elution times are given in brackets): L-leucyl-
D-aspartate (89 min); L-leucyl-L-aspartate (102 min); 
L-leucyl-D-glutamate (125 min); L-leucine (140 min) and 
L-leucyl-L-glutamate (158 min). Chromatographic analysis 
of derivatized samples of brain and spinal cord extracts 
from cat and rat did not reveal the presence of any peak 
running in an equivalent position to L-leucyl-D-aspartate. 
With the amounts of samples analysed, it was calculated that 
if D-aspartate was present, it would be so at a level of 
less than 1% of L-aspartate. In all extracts there was a 
small peak running in a position equivalent to the L-leucyl- 
D-glutamate standard; this was observed on TLC of cat 
cortex and cord extracts. The amount was between 4-6% of 
L-leucyl-L-glutamate for cat brain, rat brain and cord 
extracts and about 19% for the cat cord sample (assuming 
equal colour development values with ninhydrin for the two 
derivatives). This minor peak however, was not further 
identified and is quite possibly a derivative of some 
other amino acid in the CNS extracts.
4. DISCUSSION
It can be concluded from these results that the 
brain of cat and rat does not contain D-aspartate, at least 
not in amounts in excess of 1% of the level of the L-isomer. 
A peak, about 4-6% of the L-glutamate peak, ran in an 
equivalent position to the L-leucyl-D-glutamate standard 
in two chromatographic systems. It could represent a
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derivative of some other amino acid, possibly that of an 
unidentified amino acid which elutes just before aspartate 
in routine analyses (JAMES, 1972) of rat and cat brain 
extracts. This peak was first noticed by JOHNSTON (unpublished 
results) and was seen in extracts of 10-day-old rat CNS 
(Section III).
The use of isomer-specific enzymes, coupled with 
automated column-chromatographic amino acid analysis, should 
be a feasible method of determining optical configurations 
of amino acid samples, provided enzyme preparations free 
of contaminating amino acids can be prepared or obtained.
This was not the case in the present investigation.
The formation of diastereoisomeric dipeptide 
derivatives of amino acids by reaction with L-leucine 
N-carboxyanhydride, and subsequent separation by column 
chromatography, seems to be a convenient method of 
determining the optical configuration of an amino acid 
sample, provided a supply of L-leucine N-carboxyanhydride 
can be either obtained commercially or synthesized. The 
synthesis described here was relatively straightforward, 
although great care is necessary in the handling of the 
phosgene and in isolating the reaction in a fume-cupboard.
The separation of such derivatives by TLC should be useful 
in checking the optical purity of radiolabelled compounds.
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APPENDIX 1
All scintillation counting was done on a Beckman
LS-100, which uses an External Standard-Channels Ratio
operation as a means of correcting for counting efficiency
variations caused by sample quenching. CPM were converted
to DPM by means of this External Standard Ratio. Known 
3 14amounts of [ H] or [ c]radioactivity were added to a number 
of scintillation vials containing appropriate scintillator 
solution and a quenched series made by adding different 
volumes of chloroform. Samples were counted and the External 
Standard Ratio plotted versus counting efficiency (CPM 
obtained x 100/known DPM added). The External Standard 
channel window was set to obtain a linear relationship 
between the External Standard Ratio and efficiency; for 
each scintillator used the appropriate constants for the 
experimentally-determined straight lines were calculated 
for both isotopes and used in computer programmes written 
to convert CPM to DPM.
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APPENDIX 2
Where appropriate, weighted averages of the 
values - S.E.M. from analysis of individual experiments 
were calculated using the following equations (MORRISON
& JAMES, 1965):
W^ixiWeighted means of x values =
Lw.l
and S.E.M. of weighted mean value
1
[S.E.M. (xi)]2
1
where w
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